Shirodhara is one of Ayurveda’s most recognizable external therapies: a steady stream of warm oil or another selected liquid is poured over the forehead for a defined period under practitioner supervision. Its global popularity has made it easy to romanticize, but the more useful question is narrower and more practical: does this procedure produce measurable changes in body and mind, and how strong is the human clinical record behind those claims?

The most accurate answer is balanced. Published human work on Shirodhara is small, mixed in design quality, and often conducted with limited sample sizes. At the same time, it is not merely a decorative spa ritual: the available clinical and psychophysiological literature repeatedly points toward short-term calming effects, changes in arousal, sleep-quality measures, mood-state measures, and stress-related biomarkers. The strongest position is to view Shirodhara as a practitioner-guided complementary Ayurvedic therapy, especially relevant to stress-linked sleep difficulty, anxiety symptoms, and Vata-Pitta aggravation, rather than as a standalone treatment for serious psychiatric or neurological disorders.

Clinical Evidence at a Glance

The published human literature includes healthy-volunteer physiology studies, a small insomnia case series, a randomized crossover sleep pilot, a randomized anxiety trial in which Shirodhara was used as an add-on to an Ayurvedic medicine, and small pragmatic clinical studies. The table below replaces overconfident claims with a more careful reading of what has actually been published.

What the Physiological Signal Looks Like

The most consistent pattern in the human literature is not a claim of disease reversal, but a short-term shift toward lower arousal. Across published reports, Shirodhara has been associated with changes such as reduced subjective anxiety, lower heart rate, reduced respiratory rate, lower diastolic blood pressure, altered mood-state scores, peripheral temperature changes, and selected stress-biomarker changes. This pattern fits the clinical experience of Shirodhara as a calming therapy rather than a single-cause treatment for complex mental-health conditions.

From a modern physiology perspective, the procedure combines several inputs at once: warmth, steady tactile stimulation, rhythmic sensory repetition, a quiet treatment environment, prone or supine stillness, and the practitioner’s selected medium. Because these elements occur together, it is difficult to assign the outcome to one factor alone. Warm water comparators can also produce relaxation, which means the ritual and sensory pattern are active components; oil may add texture, unctuousness, and classical therapeutic intent rather than functioning as a simple passive carrier.

EEG, Awareness, and the Ayurvedic Language of Calm

In the Dhuri healthy-volunteer study, Shirodhara was associated with an increase in alpha rhythm and a reduction in beta activity. In ordinary language, that pattern is compatible with relaxed wakefulness rather than sedation. This is one reason Shirodhara is often described clinically as calming without necessarily being dulling.

Ayurvedically, this aligns with the broader health ideal in which the mind and senses are clear and settled. The classical definition of health attributed to Sushruta describes a healthy person as one whose dosha, agni, dhatu, and mala are in proper state and whose self, senses, and mind are content. That classical statement should not be reduced to an EEG reading, but it provides a useful bridge: Shirodhara’s best-supported role is in cultivating a calmer, more stable state of body-mind regulation.

Oil, Water, and the Question of the Medium

Ayurvedic practice does not treat every stream poured on the forehead as identical. Shirodhara is selected according to the person, condition, season, dosha pattern, and intended therapeutic action. Oil-based Shirodhara is the most represented form in the modern human literature, but classical and clinical practice also use milk, buttermilk, decoctions, and other liquids when appropriate.

The oil question is therefore best answered in layers. The pouring procedure itself appears to matter: temperature, rhythm, stillness, sound, and tactile continuity are all plausible contributors. The medium also matters in Ayurvedic practice because different liquids have different qualities and are chosen for different dosha patterns. The modern comparison between sesame oil and warm water suggests that oil-based Shirodhara may produce a more favorable subjective sleep-quality response than warm water in some participants, while also reminding us that not every outcome improves equally.

What We Can Responsibly Infer

The current clinical record supports a modest but meaningful conclusion: Shirodhara can produce measurable short-term changes consistent with relaxation, reduced arousal, and improved subjective well-being in selected settings. It is most responsibly presented as an adjunctive therapy for stress-related complaints, mild anxiety symptoms, and sleep disturbance patterns, especially when used within a broader Ayurvedic plan that includes sleep routine, diet, daily rhythm, and appropriate internal medicines when prescribed.

• Most defensible role: complementary support for stress-linked sleep difficulty, nervous-system overarousal, and Vata-Pitta aggravation.
• Best-supported outcomes: short-term relaxation, subjective anxiety reduction, mood-state improvement, selected physiological shifts, and subjective sleep-quality improvement in small studies.
• Weaker claims: durable long-term cure of insomnia, anxiety disorders, PTSD, depression, or hypertension by Shirodhara alone.
• Protocol reality: published protocols range from single sessions to multi-day or multi-week courses; the ideal number of sessions is not yet settled.
• Medium selection: oil, milk, buttermilk, and decoction should be chosen according to clinical assessment rather than trend or spa preference.

What Remains Unsettled

Important questions remain because the literature is still small and heterogeneous. The available studies do not yet establish a single best protocol, a precise dose-response curve, or clear durability of benefit beyond short follow-up windows.

• Dose and duration: the minimum effective session length, ideal session frequency, and best total course length remain unclear.
• Durability: longer follow-up is needed to understand how long benefits persist after a treatment course ends.
• Medium-specific effects: more direct comparisons are needed between oil, water, milk, buttermilk, and specific medicated oils.
• Component separation: future work should better distinguish the effects of oil, warmth, tactile rhythm, quiet rest, practitioner contact, and expectation.
• Patient selection: Ayurvedic theory would expect different responses by prakriti, vikriti, dosha state, season, age, and strength, but these variables are rarely tested rigorously.
• Clinical comparison: Shirodhara has not been adequately compared with standard treatments such as CBT-I for insomnia, psychotherapy for anxiety, or prescribed psychiatric medicines.

Practical Implications

For patients and practitioners, the practical takeaway is neither hype nor dismissal. Shirodhara has a reasonable place as a calming, sensory, external Ayurvedic therapy when performed properly and selected appropriately. It should be integrated into a complete plan rather than treated as a substitute for diagnosis, mental-health care, sleep-disorder evaluation, or medication management.

• It may be considered as adjunctive support for stress-linked sleep disturbance, mild anxiety symptoms, restlessness, and Vata-Pitta aggravation under qualified supervision.
• It should not be used as a standalone treatment for severe anxiety, panic disorder, PTSD, major depression, bipolar disorder, psychosis, suicidal thoughts, uncontrolled hypertension, or treatment-resistant insomnia.
• Oil selection, temperature, stream height, session length, hygiene, and patient screening are part of the therapy, not cosmetic details.
• Internal herbs such as ashwagandha, brahmi, jatamansi, or other medicines should be used only when individually prescribed; they should not be casually combined with Shirodhara or psychiatric medication without professional guidance.
• Anyone with worsening mental-health symptoms, severe insomnia, fainting, acute illness, skin infection, scalp wounds, pregnancy-related concerns, or complex medical conditions should consult a qualified healthcare provider before undergoing the therapy.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Shirodhara should be performed by a trained Ayurvedic practitioner after appropriate assessment. Anxiety disorders, depression, insomnia, hypertension, and neurological symptoms can have serious underlying causes and may require evaluation by a qualified healthcare provider or mental-health professional. Do not stop or change prescribed medicines without consulting your treating clinician.

References

1. Shirodhara: A psycho-physiological profile in healthy volunteers (2013), PubMed Central
2. Easyayurveda (easyayurveda.com)
3. Easyayurveda (easyayurveda.com)
4. Easyayurveda (easyayurveda.com)
5. Using a healing robot for the scientific study of shirodhara. Altered states of consciousness and decreased anxiety through Indian dripping oil treatments (2005), PubMed
6. Pharmaco-physio-psychologic effect of Ayurvedic oil-dripping treatment using an essential oil from Lavendula angustifolia (2008), PubMed
7. Psychoneuroimmunologic effects of Ayurvedic oil-dripping treatment (2008), PubMed
8. The role of psychic factors in pathogenesis of essential hypertension and its management by Shirodhara and Sarpagandha Vati (2010), PubMed Central
9. Clinical efficacy of Manasamitra Vataka (an Ayurveda medication) on generalized anxiety disorder with comorbid generalized social phobia: a randomized controlled study (2012), PubMed
10. Shirodhara: A psycho-physiological profile in healthy volunteers (2013), PubMed
11. Ayurvedic therapy (shirodhara) for insomnia: a case series (2014), PubMed
12. Effects of Ayurvedic Oil-Dripping Treatment with Sesame Oil vs. with Warm Water on Sleep: A Randomized Single-Blinded Crossover Pilot Study (2016), PubMed Central
13. Accesson (accesson.kr)
14. Impact of Shirodhara on biological markers of stress: A case study (2021), PubMed
15. Dharishahayurveda (dharishahayurveda.com)
16. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults (2012), PubMed
17. Efficacy of Ashwagandha (Withania somnifera [L.] Dunal) in improving cardiorespiratory endurance in healthy athletic adults (2015), PubMed
18. Evaluation of age-related changes in lumbar facet joints using T2 mapping (2020), PubMed
19. Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults (2010), PubMed
20. Alanine scanning mutagenesis of anti-TRAP (AT) reveals residues involved in binding to TRAP (2008), PubMed
21. D-dimer as a prognostic biomarker for mortality in chronic obstructive pulmonary disease exacerbation (2015), PubMed
22. Electroacupuncture Alleviates Pain-Related Emotion by Upregulating the Expression of NPS and Its Receptor NPSR in the Anterior Cingulate Cortex and Hypothalamus (2020), PubMed

Thalam, also written as Talam, is a traditional Kerala Ayurvedic external therapy in which a medicated powder or paste is applied to a small, selected area on the crown of the head. It is usually centered over the bregma region, the point where the sagittal and coronal sutures meet, and is used as a supportive head therapy for conditions in which the head, senses, sleep, and mind need calming or dosha-specific regulation.

Thalam is best understood as a localized form of medicine application to the head, closely related in principle to Shirolepa, Shiropichu, and other Murdha Taila procedures. Classical Ayurveda gives special importance to the head as the seat of vital functions, sense organs, and higher regulation. Sushruta’s marma doctrine also treats the cranial region with great care, describing Adhipati and Simanta marmas among the vital points of the head. For that reason, Thalam is applied gently and therapeutically; it is not a pressure technique or a forceful stimulation of the crown.

Why the Crown: Classical and Anatomical Rationale

The crown area used in Thalam corresponds in modern anatomical language to the bregma region, where the coronal and sagittal sutures meet. In traditional Kerala practice, this small cranial area is identified as the practical site for the shallow application of medicine. The significance is not that medicine is pushed into the skull, but that the scalp, skin, vessels, nerves, and sensory field of the head are engaged through a mild, sustained, dosha-specific external application.

Ayurveda explains the therapeutic value of external application through concepts such as Bhrajaka Pitta, the skin-associated function that helps process substances applied to the body surface. Modern anatomy also recognizes the scalp as a richly supplied and highly sensitive tissue, receiving blood supply from branches such as the superficial temporal and occipital arteries and having dense sensory innervation. In practice, the combination of selected herbs, proper medium, gentle contact, temperature, rest, and reduction of sensory stimulation creates a calming therapeutic setting.

The crown is also discussed in broader Indic subtle anatomy as a spiritually important region, but the clinical Ayurvedic use of Thalam does not depend on mystical exaggeration. Its practical value lies in proper diagnosis, correct selection of the paste and medium, careful application, and appropriate post-care.

Classical and Traditional Formulations for Thalam

The medicine used for Thalam is selected according to the person’s dosha presentation, the quality of the head symptoms, the season, and the intended therapeutic effect. Kerala practice commonly uses choornas such as Rasnadi Choornam and Kachuradi Choornam, mixed with a suitable medium such as water, milk, sesame oil, castor oil, coconut oil, ghee, or Ksheerabala Taila. The medium is as important as the powder: warming, oily media are generally chosen for dry Vata patterns, while cooler and lighter media are preferred where Pitta heat or Kapha heaviness predominates.

Detailed Protocol: Rasnadi Thalam for Vata-Kapha Head Heaviness and Sleep Support

Rasnadi Thalam is most suitable when sleep difficulty is accompanied by heaviness of the head, coldness, sinus-type congestion, post-bath head discomfort, or Vata-Kapha aggravation. It is not the best choice when the scalp is hot, inflamed, very sensitive, or when the person has a strong Pitta presentation with burning and heat, unless the medium and formulation are modified by a practitioner.

Preparation of the Paste

Use clean, finely powdered Rasnadi Choornam from a reliable Ayurvedic pharmacy. For a paste application, mix one to two teaspoons of the powder with enough warm water, milk, castor oil, sesame oil, or Ksheerabala Taila to form a smooth paste that stays in place without dripping. The paste should be comfortably lukewarm or room temperature, never hot. For a lighter traditional post-bath application, only one to two pinches of the powder may be rubbed gently over the crown after the hair has been dried.

Patient Preparation

The person should sit comfortably or recline with the head supported. The crown area is exposed by parting the hair, and the scalp should be clean, dry, and free from wounds, active infection, or irritation. The setting should be quiet, warm, and free from cold wind or strong air conditioning. If the person is anxious or overstimulated, a few minutes of slow breathing before application helps prepare the body for the therapy.

Application Technique

Apply the paste gently over a small circular area at the crown, usually about three to five centimeters across, rather than covering the entire scalp. Traditional descriptions keep the application restricted and not excessively thick; a compact mound or patch is sufficient. The paste may be covered with a clean cotton pad, gauze, or suitable leaf to maintain contact and prevent drying too quickly. The head should not be tightly bound, and no strong pressure should be applied over the crown.

Resting Period

The person should rest quietly while the paste remains in place. Conversation, phone use, reading, work, and bright screens are best avoided because the therapy is intended to reduce sensory load. A practical session often lasts 30-60 minutes, with the duration adjusted according to comfort, constitution, age, season, and the strength of the formulation. If burning, itching, dizziness, sharp headache, nausea, or unusual discomfort occurs, the paste should be removed immediately.

Removal and Post-Care

The paste should be removed gently with a soft cloth or spatula, and the scalp may be wiped with lukewarm water. The head should be kept protected from cold air, wind, and immediate head washing unless irritation requires washing. For sleep support, Thalam is often better scheduled in the late afternoon or early evening, so the person can remain quiet afterward and carry the calming effect into the night.

Key Herbal Actions in Thalam

Rasnadi Choornam: Rasnadi Choornam is a traditional external powder used over the scalp and forehead for headache, cold, running nose, sinus-type heaviness, dizziness, and Kapha-Vata aggravation in the head region. Its ingredients commonly include Rasna, Amukkura, Devadaru, Vacha, Musta, Vyosha, Ushira, Chandana, and other herbs, with the exact composition depending on the classical or pharmacy tradition followed.

Kachuradi Choornam: Kachuradi Choornam is an external-use preparation traditionally applied for headache, burning sensation, dizziness, and sleep disturbance associated with Pitta-Kapha imbalance. Its ingredients include Kachora, identified in this formulation tradition as Curcuma zedoaria, along with Dhatri, Manjishta, Yashti, Devadaru, Kumkuma, camphor, Ushira, and other substances.

Ksheerabala Taila: Ksheerabala Taila is a Vata-pacifying oil prepared with Bala, cow’s milk, sesame oil, and water. In Thalam, it may be used as a nourishing medium when dryness, restlessness, Vata aggravation, or tension is prominent. It should be avoided or modified when heavy oiliness, Kapha congestion, acute inflammation, or scalp intolerance is present.

Cooling herbs and media: Chandana, Ushira, Amalaki-based preparations, ghee, coconut milk, and coconut oil are commonly chosen when heat, burning sensation, irritability, or Pitta aggravation is prominent. Cooling Thalam should still be applied carefully, because excessive coldness on the head can trigger discomfort in some Vata-sensitive individuals.

Vacha safety: Some traditional head powders contain Vacha. Because Acorus calamus contains asarone constituents, strong or repeated use of Vacha-containing preparations should be supervised, especially in pregnancy, children, frail patients, people with seizures, and those with sensitive skin or complex medication use.

Thalam for Insomnia and Anxiety: Ayurvedic Selection

Thalam is most useful when it is matched to the person’s presentation rather than applied as a one-formula-fits-all sleep remedy. In a Vata pattern, the person may be restless, sensitive, tense, or unable to settle; a warm, mildly oily, Vata-pacifying application may be chosen. In a Pitta pattern, the person may feel heat in the head, irritability, sharpness, or burning; a cooler preparation is more appropriate. In a Kapha pattern, heaviness, congestion, dullness, and excess oiliness may require a lighter and less oily approach.

Integration with Other Ayurvedic Therapies

Thalam is often used alongside other Ayurvedic therapies rather than as a stand-alone treatment. Depending on the person’s constitution and condition, a practitioner may combine it with Shiroabhyanga, Shiropichu, Shirodhara, Pada Abhyanga, Nasya, or internal medicines. The order and selection matter: a person with dry Vata restlessness may need nourishment and grounding, while a person with Pitta heat may first need cooling and simplification.

For sleep support, Thalam works best when paired with a suitable evening routine, light and timely dinner, reduced screen exposure before bed, calm breathing, and regular sleep timing. Internal medicines such as classical tablets, churnas, or sleep-supporting herbs should not be self-prescribed simply because they are traditional. They should be selected according to constitution, digestion, age, medications, and diagnosis. For additional sleep routines, see Beyond Ashwagandha: 5 Sleep Remedies.

Safety Considerations and Contraindications

Thalam should not be performed over active scalp infection, open wounds, fresh head injury, unexplained severe headache, acute fever, or acute neurological symptoms. Avoid contact with the eyes, nose, and mouth. Strongly aromatic or camphor-containing preparations should be used cautiously in children, pregnancy, seizure disorders, respiratory sensitivity, and frailty. A small patch test is sensible for people with sensitive skin or allergy history.

Stop the application if there is burning, itching, rash, dizziness, nausea, sharp headache, unusual sleepiness, agitation, or any worsening of symptoms. People taking psychiatric medicines, sedatives, anti-seizure medicines, anticoagulants, or multiple long-term medications should consult their healthcare provider before adding even external therapies, especially if the therapy contains potent herbs, essential oils, camphor, or Vacha.

Home Practice Adaptation

A simple home adaptation should be mild and conservative. After a head bath, dry the hair well and apply one to two pinches of Rasnadi Choornam lightly over the crown if the person tends toward cold, heaviness, or post-bath head discomfort. For bedtime use, a small crown application may be prepared with a gentle medium selected for the person’s constitution, but strong powders, camphor-heavy mixtures, and Vacha-containing preparations should not be left on overnight without professional guidance.

Home Thalam should be treated as supportive care, not as a substitute for diagnosis. Chronic insomnia, anxiety, panic episodes, depression, severe headaches, neurological symptoms, and long-standing sleep disturbance require proper evaluation. Consult a qualified Ayurvedic practitioner and a qualified healthcare provider before beginning treatment, and do not stop or reduce prescribed psychiatric or sleep medication without the guidance of the prescribing clinician. For fatigue that often accompanies poor sleep, see Ayurvedic Approach to Chronic Fatigue.

References

1. Jahm (jahm.co.in)
2. Radiopaedia (radiopaedia.org)
3. Wisdomlib — classical text
4. Charaka Samhita — Marma
5. Easyayurveda (easyayurveda.com)
6. Ayushdhara (ayushdhara.in)
7. NCBI
8. NCBI
9. Ayurmedinfo (ayurmedinfo.com)
10. Ijapr (ijapr.in)
11. Ayurmedinfo (ayurmedinfo.com)
12. Ayurmedinfo (ayurmedinfo.com)
13. The Ayurvedic drug, Ksheerabala, ameliorates quinolinic acid-induced oxidative stress in rat brain (2010), PubMed Central
14. Mdpi (mdpi.com)
15. Easyayurveda (easyayurveda.com)

The Ayurvedic Pharmacopoeia of India identifies Tagara as the predominantly dried rhizome and stolon, with a small portion of root, of Valeriana wallichii DC. The monograph calls it Indian valerian and describes a strong odour reminiscent of isovaleric acid, with a bitter, somewhat camphoraceous taste. Current botanical databases treat Valeriana wallichii as a synonym of the accepted name Valeriana jatamansi Jones ex Roxb. This plant must not be confused with Nardostachys jatamansi, the distinct Ayurvedic drug Jatamansi.

Tagara and Western Valerian: What Can Actually Be Compared

Tagara and European valerian belong to the same genus, but they are not interchangeable species. European valerian products generally use Valeriana officinalis, whereas the official Ayurvedic Tagara monograph uses V. wallichii, now commonly accepted as V. jatamansi. Their underground parts contain complex mixtures of volatile oils, sesquiterpenes, iridoids and related compounds, but the proportions vary with species, chemotype, growing region, harvest, storage and extraction method.

• Botanical identity matters: a label stating only “valerian” is not enough. A Tagara product should identify the botanical source and the plant part used.
• Standardisation is not automatically transferable: a valerenic-acid specification developed for a V. officinalis extract should not be assumed to define the quality or clinical effect of Tagara.
• Superiority has not been established: no reliable human head-to-head trial was found showing that Tagara acts faster, relaxes muscle more strongly or treats “Vata-Pitta insomnia” better than European valerian.
• Mechanism remains uncertain: valerian research has explored GABA-related pathways and several constituent groups, but authoritative reviews state that no single accepted active compound or mechanism explains the effects of valerian preparations.

Claims that Tagara contains a uniquely broader sedative, antispasmodic and anxiolytic profile than V. officinalis are therefore premature. Chemical differences may be real, but chemical difference alone does not prove clinical superiority. Product identity and extraction method are especially important because two preparations bearing the same common name may not deliver comparable constituents.

The Ayurvedic Pharmacopoeia Profile

The Ayurvedic Pharmacopoeia of India gives Tagara the tastes katu (pungent), tikta (bitter) and kashaya (astringent); the qualities laghu (light) and snigdha (unctuous); ushna virya (heating potency); and katu vipaka (pungent post-digestive effect). Its listed actions are vishaghna, tridoshahara, raktadoshahara and manasadoshahara. This corrects the frequently repeated description of Tagara as teekshna in guna or as solely Vata-pacifying.

The same monograph lists netraroga, apasmara, unmada and shiroroga among its therapeutic uses. These Sanskrit categories should not be casually equated with modern diagnoses, and they do not justify self-treatment of epilepsy, psychosis or neurological disease. The monograph does not list insomnia among these therapeutic-use entries, although later Ayurvedic clinical literature has studied Tagara in Anidra.

The pharmacopoeial dose is 1–3 g of the drug in powder form. It also names Dhanvantara Taila, Mahanarayana Taila, Devadarvadyarishta and Jatiphaladi Churna as important formulations containing Tagara. The monograph does not prescribe a universal bedtime recipe with milk and honey, does not specify a standardised capsule containing 0.8% valerenic acid, and does not provide a paediatric sleep dose.

What Human Research on Tagara Shows

The most directly relevant published clinical study is a 2015 comparative trial in AYU. Thirty-four people with primary insomnia were enrolled and 30 completed the study, with 15 completers in a Tagara group and 15 in a Jatamansi group. Tagara powder and Jatamansi powder were each administered at 4 g with milk three times daily after food for one month, and symptoms were assessed using the Athens Insomnia Scale and additional symptom scores.

The authors reported improvement within both groups, with larger percentage changes in the Tagara group for initiation of sleep, sleep duration, disturbed sleep and disturbance of routine work. These findings are encouraging, but the study was small, compared two active Ayurvedic drugs rather than using a placebo, and did not provide the kind of blinding and objective sleep measurement expected in a definitive insomnia trial. The reported 12 g daily Tagara protocol also exceeds the 1–3 g powder dose stated in the pharmacopoeial monograph and should not be copied without specialist supervision.

Because of these limitations, the trial cannot establish how much of the observed change came from Tagara, expectation, study contact, natural fluctuation or other factors. It also cannot establish long-term safety, an optimal dose, equivalence to prescription hypnotics or superiority over cognitive behavioural therapy for insomnia. The claimed 2021 placebo-controlled Phytomedicine trial of 86 adults, with a 500 mg extract and precisely stated PSQI improvements, could not be verified and has been removed.

What Preclinical Research Shows

A 2012 rat study in Phytomedicine evaluated an aqueous V. wallichii root extract using EEG and EMG recordings. Oral doses of 200 and 300 mg/kg reduced sleep latency and wakefulness and increased non-rapid-eye-movement and total sleep in the animals. The investigators also measured changes in several brain monoamines. This supports biological plausibility, but an animal dose cannot be converted directly into a self-care dose, and a rat sleep model does not prove effectiveness in human chronic insomnia.

Research across valerian species has proposed effects involving GABA signalling, volatile-oil constituents, valerenic-acid derivatives and valepotriates. Yet preparations differ substantially, valepotriates can be unstable, and even the better-studied V. officinalis has produced inconsistent clinical results. It is therefore inaccurate to say that Tagara works “like a benzodiazepine without tolerance, dependence or withdrawal.” That comparison has not been established, and abrupt discontinuation after prolonged valerian use has occasionally been associated with withdrawal-like symptoms.

Using Tagara More Responsibly

For an adult considering Tagara, the safest starting point is not a universal internet formula but confirmation of the drug, the reason for use and the person’s medications and health conditions. The API range of 1–3 g powder is a pharmacopoeial reference, not a personalised prescription. An Ayurvedic practitioner may select a different preparation, vehicle, timing or formulation according to the patient and the clinical context.

• Choose a product that states Valeriana wallichii or its accepted synonym Valeriana jatamansi, identifies the rhizome/root material and provides batch testing or pharmacopoeial quality information.
• Do not assume that a capsule standardised for European valerian is an authenticated Tagara product.
• Use only one new sedating product at a time, so that benefit or adverse effects can be recognised.
• Keep a sleep diary recording bedtime, estimated sleep latency, awakenings, wake time, daytime sleepiness, caffeine, alcohol and other sleep medicines.
• Stop and seek advice if it causes marked next-day drowsiness, agitation, dizziness, abdominal symptoms, an allergic reaction or worsening sleep.

For Difficulty Falling or Staying Asleep

Tagara should be considered only as an adjunct to a proper insomnia plan. Chronic insomnia can be maintained by irregular sleep timing, excessive time in bed, conditioned arousal, pain, depression, anxiety, medicines, alcohol, sleep apnoea or restless legs syndrome. Cognitive behavioural therapy for insomnia is recommended as first-line treatment for adults with chronic insomnia because it addresses the behavioural and cognitive processes that perpetuate the problem.

For Anxiety, Cramps or Muscle Tension

The original article supplied exact regimens for anxiety-driven insomnia, menstrual cramps, neck spasm and topical compresses. Those protocols were removed because no reliable clinical evidence or authentic classical prescription was found for those precise combinations and doses. Evidence for valerian in anxiety, dysmenorrhoea and muscle spasm remains insufficient, and severe cramps, recurrent spasm or persistent anxiety deserve diagnosis rather than repeated sedation.

For Children

No paediatric Tagara dose should be published as routine home treatment for “hyperactivity” or poor sleep. The API monograph provides a powder dose but no child-sleep regimen, while European regulatory guidance for V. officinalis does not recommend use below 12 years because adequate safety and efficacy data are lacking. A child with persistent insomnia, snoring, breathing pauses, unusual movements, anxiety or daytime impairment should be assessed by a paediatric clinician.

Dosage and Evidence Reference

The table separates official Ayurvedic information from research protocols and unsupported internet dosing. A research dose is not a recommendation, and the safety findings for European valerian cannot simply be assumed to apply identically to every Tagara preparation.

Safety, Interactions and Contraindications

Direct long-term safety data for Tagara are sparse. Safety guidance is often extrapolated from the better-studied European valerian, so it should be applied cautiously rather than presented as species-specific certainty. Valerian products can cause headache, dizziness, gastrointestinal upset, mental dullness, uneasiness, vivid dreams or occasional excitability; next-morning sleepiness has also been reported with some preparations.

• Alcohol and sedatives: avoid combining Tagara with alcohol, benzodiazepines, prescription hypnotics, sedating antihistamines, opioids or other CNS depressants unless the prescribing clinician has reviewed the combination.
• Driving and machinery: do not drive, ride a motorcycle or operate machinery if drowsy or mentally slowed. European regulatory guidance warns that valerian may impair these activities.
• Pregnancy and breastfeeding: avoid self-use because adequate safety data are not available.
• Children: do not use as a routine sedative. Seek professional assessment and dosing advice.
• Surgery and anaesthesia: disclose Tagara and all herbal products to the surgical team in advance; sedative effects may complicate anaesthesia planning.
• Long-term or high-dose use: do not assume absence of tolerance, dependence, withdrawal or liver risk. Medical review is appropriate before prolonged use or if symptoms occur.

Do not stop a prescribed sleep, anxiety or seizure medicine in order to replace it with Tagara. Anyone taking multiple medicines, living with liver disease, having a history of unusual reactions to sedatives, or using Tagara regularly should discuss it with a physician and a qualified Ayurvedic practitioner.

When Insomnia Needs Medical Assessment

Seek evaluation when insomnia persists, causes daytime impairment, or is accompanied by loud snoring, witnessed breathing pauses, gasping, uncomfortable urges to move the legs, severe depression, panic, substance use, unusual nighttime behaviour or dangerous daytime sleepiness. A sleep diary can help a clinician distinguish insufficient sleep opportunity, circadian disruption and chronic insomnia from other sleep disorders.

For more on sleep-supportive routines, see our guides to the Ayurvedic gut-brain axis and sleep and Ayurvedic sleep optimization. These lifestyle discussions should complement—not delay—evaluation of persistent or severe symptoms.

A Balanced Conclusion

Tagara is a genuine Ayurvedic drug with a clearly documented pharmacopoeial identity, properties and powder dose. A small comparative clinical study and an animal sleep study offer preliminary support for further research, but they do not justify claims of guaranteed sleep within days, superiority to European valerian, benzodiazepine-like efficacy without dependence, or broad treatment of anxiety, cramps and muscle spasm. The most defensible approach is authenticated material, conservative practitioner-guided use, careful attention to sedation and interactions, and evidence-based treatment of the underlying sleep disorder.

Consult a qualified Ayurvedic practitioner and healthcare provider before using Tagara, especially if you take sedatives, anxiety medicines, antidepressants, opioids, antihistamines, seizure medicines or other products that affect alertness. Do not drive or operate machinery after taking it if you feel drowsy. This article does not replace diagnosis or treatment of insomnia, anxiety, epilepsy or other medical conditions.

References

1. Ayurvedic Pharmacopoeia of India
2. Echarak (echarak.ayush.gov.in)
3. Powo (powo.science.kew.org)
4. Powo (powo.science.kew.org)
5. A comparative clinical study on the effect of Tagara (Valeriana wallichii DC.) and Jatamansi (Nardostachys jatamansi DC.) in the management of Anidra (primary insomnia) (2015), PubMed Central
6. Valeriana wallichii root extract improves sleep quality and modulates brain monoamine level in rats (2012), PubMed
7. NIH Office of Dietary Supplements
8. NCCIH
9. Ema (ema.europa.eu)
10. Mskcc (mskcc.org)
11. Acponline (acponline.org)
12. Nhlbi (nhlbi.nih.gov)

The most accurate comparison is therefore about clinical role rather than declaring a winner. Human trials have compared ashwagandha with placebo, and one pragmatic trial compared a multicomponent naturopathic program containing ashwagandha with psychotherapy. No direct matched human trial has established that ashwagandha is equivalent to lorazepam, an SSRI, an SNRI, or buspirone. Ashwagandha should not be used to replace these medicines without professional assessment.

Understanding the Comparison

“Anxiolytic” covers medicines with different purposes. Benzodiazepines such as lorazepam can suppress acute anxiety but may cause sedation, physical dependence, and withdrawal reactions. Clinical guidance limits benzodiazepines in generalized anxiety disorder to short-term use during crises. SSRIs are commonly offered when a person with generalized anxiety disorder chooses drug treatment, while other medicines may be selected according to diagnosis, response, contraindications, and adverse effects.

Ashwagandha extracts are multicomponent botanical products rather than a single defined molecule. Their composition varies with plant part, extraction method, solvent, and standardization. Withanolides are prominent constituents, but proposed effects on stress pathways and neurotransmission do not establish that an extract works like a benzodiazepine or antidepressant. A milligram amount from one extract cannot automatically be treated as equivalent to the same milligram amount from another.

Clinical Evidence at a Glance

The following studies are frequently cited in discussions of ashwagandha, stress, anxiety, and sleep. Their designs and populations matter because several did not enroll patients with a formally diagnosed anxiety disorder, and none directly compared ashwagandha with a prescription anxiolytic.

What the Evidence Supports

A 2021 review summarized by the U.S. National Institutes of Health identified seven stress-and-anxiety trials involving 491 adults. Participants received ashwagandha or placebo for six to eight weeks, and the preparations and daily doses varied widely. Overall results favored ashwagandha on several subjective stress or anxiety measures and sometimes on cortisol, but the trials were generally small, brief, and heterogeneous. Later randomized trials and meta-analyses add supportive findings without resolving product differences or establishing equivalence to prescription treatment.

Stress and Anxiety Symptoms

Some standardized ashwagandha extracts have reduced perceived stress and certain anxiety scores in selected adults during short-term trials. Much of this evidence comes from otherwise healthy people with self-reported stress rather than from large, independently replicated trials in panic disorder, social anxiety disorder, post-traumatic stress disorder, or severe generalized anxiety disorder. Improvement on a rating scale is clinically relevant, but it is not the same as demonstrated remission of a diagnosed disorder.

Cortisol and Stress Biology

Several placebo-controlled trials reported lower serum or morning cortisol after ashwagandha use. Cortisol is a physiological marker influenced by time of day, sleep, illness, exercise, and many other factors; lowering it does not by itself establish recovery from an anxiety disorder. Cortisol reduction should not be treated as a unique pharmacological advantage over every prescription anxiolytic or used alone to select treatment.

Sleep

A 2021 systematic review and meta-analysis found a small overall improvement in sleep with ashwagandha compared with placebo, with larger effects in participants who had insomnia, in studies lasting at least eight weeks, and at daily doses of 600 mg or more. These findings do not make ashwagandha a rescue sedative. Persistent insomnia warrants assessment for psychiatric, respiratory, endocrine, medication-related, substance-related, and other medical causes.

Onset and Clinical Role

Ashwagandha outcomes in the cited trials were assessed after repeated daily use over approximately six to twelve weeks, not minutes or hours. It is therefore unsuitable as an acute treatment for a panic attack, severe agitation, dangerous withdrawal, or another psychiatric crisis. Its most plausible role is as a professionally supervised complementary option for some adults with stress-related symptoms, not as an emergency medicine or an automatic replacement for psychotherapy or prescribed treatment.

Where Prescription Treatment Remains Essential

Clinical severity and diagnosis determine treatment. Guideline-based care may include cognitive behavioral therapy, an SSRI or another appropriate medicine, careful follow-up, and short-term crisis measures when necessary. Ashwagandha is not an established sole treatment for severe or disabling anxiety, recurrent panic attacks, obsessive-compulsive disorder, post-traumatic stress disorder, major depression with anxiety, mania, psychosis, substance withdrawal, or perinatal psychiatric emergencies.

• Acute panic or crisis: A botanical supplement does not provide predictable rescue treatment. New chest pain, fainting, severe breathlessness, confusion, or neurological symptoms also require medical evaluation rather than being assumed to be anxiety.
• Marked functional impairment: Inability to work, sleep, eat, leave home, or care for oneself calls for prompt professional assessment and an individualized treatment plan.
• Self-harm or suicide risk: Suicidal thoughts, intent, planning, or severe hopelessness require urgent local emergency or crisis support.
• Benzodiazepine use: Physical dependence can develop even when a benzodiazepine is taken as prescribed. Abrupt discontinuation or rapid dose reduction can produce serious withdrawal, including seizures; tapering must be directed by the prescriber.

Ayurvedic Context and Product Identity

The Ayurvedic Pharmacopoeia of India identifies Ashvagandha as the dried mature root of Withania somnifera. A Ministry of AYUSH advisory also distinguishes this root identity from leaf-containing products marketed in the name of Ayurveda. Modern clinical extracts may differ from classical root powder in extraction ratio, excipients, plant part, and withanolide specification, so their trial doses should not be converted directly into doses for churna, avaleha, ghrita, or another Ayurvedic preparation.

Ayurvedic treatment is individualized rather than built from a universal fixed “anxiety stack.” A qualified Ayurvedic practitioner may consider constitution, strength, digestion, sleep, diet, concurrent illness, and current medicines before selecting the drug, form, dose, timing, adjuvant, and duration. Fixed combinations of Ashwagandha, Brahmi, Shankhpushpi, Jatamansi, or Tagara should not be presented as a classically mandated protocol, and modern standardized-extract doses should not be attributed to classical texts.

Using Ashwagandha Alongside Medication

Combining a supplement with treatment is not automatically safer than using either alone. Ashwagandha can cause drowsiness and may interact with sedatives, anticonvulsants, thyroid hormone, immunosuppressants, and medicines for diabetes or high blood pressure. A person taking lorazepam, clonazepam, diazepam, a sleep medicine, or another central nervous system depressant should obtain prescriber approval before adding it because sedation and impaired alertness may increase.

• Thyroid disease: Ashwagandha may affect thyroid function and has been associated with reports of thyrotoxicosis. People with thyroid disorders or those taking thyroid hormone need clinician guidance and appropriate monitoring.
• Autoimmune disease or immunosuppression: Use is not recommended without specialist approval because of possible effects on immune activity and potential interaction with immunosuppressive medicines.
• Surgery: Stop-and-start decisions should be made with the surgical team; NCCIH advises against use around surgery.
• Driving and machinery: Drowsiness can occur. Avoid driving or hazardous work until individual effects and medicine interactions are clear.

Dose, Duration, and Product Differences

Trial doses describe what investigators tested; they are not a personal prescription. In the seven trials summarized by NIH, extract doses ranged from 240 to 1,250 mg daily, while one study used a much larger amount of whole-root granules. Commonly cited trials used 240 mg once daily, 250 or 600 mg daily, or 300 mg twice daily for six to ten weeks. The varied preparations prevent a single evidence-based dose from being transferred to every commercial product.

Check whether the label specifies root, leaf, or root-and-leaf extract; the extraction ratio; the amount per serving; the withanolide specification; and any additional active ingredients. A higher withanolide percentage is not automatically more appropriate, and branded extracts with different compositions should not be treated as interchangeable. Bring the exact label or a photograph of it to the prescribing clinician and qualified Ayurvedic practitioner.

Safety and Disclaimer

This article is for education and does not constitute medical advice. Short-term use for up to about three months appears generally tolerated in trials, but long-term safety is not established. Reported adverse effects include drowsiness, stomach upset, loose stools, nausea, vomiting, and rare clinically apparent liver injury. Avoid ashwagandha during pregnancy and breastfeeding, and obtain medical advice before use with thyroid or autoimmune disorders, liver disease, upcoming surgery, or any regular medication.

Stop the product and seek medical care for jaundice, dark urine, severe itching, persistent vomiting, unusual fatigue, or upper abdominal pain. Do not discontinue, reduce, or substitute a prescription anxiolytic on the basis of supplement response alone. A validated symptom scale or sleep diary can help document change, but it should supplement—not replace—clinical review. Decisions about continuing either ashwagandha or a prescription medicine should be made with a qualified Ayurvedic practitioner and the healthcare professional managing the anxiety disorder.

References

1. NIH Office of Dietary Supplements
2. NCCIH
3. An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera) (2014), PubMed
4. A double-blind, placebo-controlled evaluation of the anxiolytic efficacy ff an ethanolic extract of withania somnifera (2000), PubMed
5. Journals (journals.plos.org)
6. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults (2012), PubMed
7. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults (2012), PubMed Central
8. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study (2019), PubMed
9. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study (2019), PubMed Central
10. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study (2019), PubMed
11. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study (2019), PubMed Central
12. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study (2019), PubMed
13. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study (2019), PubMed Central
14. Journals (journals.plos.org)
15. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial (2015), PubMed
16. Nice (nice.org.uk)
17. Cks (cks.nice.org.uk)
18. FDA
19. Ministry of AYUSH
20. Ayush (ayush.delhi.gov.in)
21. NCBI

Ayurvedic Understanding of Anxiety and Breath

Ayurveda does not reduce anxiousness to one single pattern. In practice, an anxious presentation is assessed through the qualities showing up in the body and mind: movement, heat, heaviness, dryness, congestion, sleep pattern, appetite, and emotional tone. Vata is linked with movement and higher mental activity; when disturbed, it commonly presents with irregularity, restlessness, fearfulness, tremor-like agitation, shallow breath, variable sleep, and difficulty settling. Pitta-predominant agitation tends to feel hot, sharp, urgent, irritable, perfectionistic, and reactive. Kapha-predominant distress tends to feel heavy, dull, withdrawn, slow, congested, and stuck.

Prana moves through the Pranavaha Srotas, the Ayurvedic channel system associated with vital breath and respiration. Classical Ayurvedic sources place the roots of Pranavaha Srotas in the heart region and major internal channels, showing that breath is treated as a whole-body life process rather than a mechanical lung action alone. Pranayama uses this breath–mind connection deliberately: the practice is not simply “taking deep breaths,” but choosing the right rhythm, temperature, sound, nostril pattern, and intensity for the state in front of you.

Modern Clinical Context for Breathwork

Structured breathing practices have been evaluated as supportive tools for stress and anxiety symptoms. A 2023 scoping review of breathwork interventions in adults with clinically diagnosed anxiety disorders found improvement across several intervention types, while also noting variation in study design and the need for stronger trials. A 2023 meta-analysis of randomized controlled trials found breathwork associated with lower self-reported stress, anxiety, and depressive symptoms compared with non-breathwork controls. A Stanford-led randomized study of brief daily breathing practices found that exhale-focused cyclic sighing improved mood and reduced respiratory rate more than mindfulness meditation over the study period.

For pranayama specifically, clinical work on slow breathing has reported shifts toward parasympathetic cardiac autonomic activity and improvement in anxiety-related measures after regular practice. These findings fit the traditional instruction to practice gradually and skillfully: classical Hatha Yoga cautions that improper or forceful pranayama can create problems, while well-guided practice supports steadiness.

The Five Pranayama Sequences

The following sequences are organized by presentation rather than by diagnosis. Choose the practice that matches the day’s dominant quality: restless and scattered, hot and irritable, dull and heavy, mixed and pressured, or wakeful at night. Practice on an empty or light stomach, keep the face soft, and never force retention or speed.

Sequence 1: Bhramari Pranayama (Humming Bee Breath) for Vata-Type Anxiety

Bhramari is a humming breath described in the Hatha Yoga tradition. The exhale is lengthened with a smooth bee-like sound, giving the mind a single steady vibration to follow. The sound, the longer exhale, and the inward sensory focus make it especially useful when anxiousness feels like racing thoughts, restlessness, and sleeplessness. Modern studies on Bhramari and humming have reported calming autonomic effects, improved relaxation markers, and increased nasal nitric oxide during humming.

Best for: Vata-type anxiousness with racing thoughts, physical restlessness, irregular breath, difficulty settling, and sleep-onset worry.

Practice: Sit comfortably with the spine upright. Close the eyes and relax the jaw. Either rest the hands on the thighs or gently close the ears with the index fingers. Inhale through the nose without strain. Exhale slowly with a continuous, soft humming sound. Let the vibration be pleasant rather than loud. Practice 5 to 10 rounds, then sit quietly for 2 to 5 minutes and feel the after-effect.

Duration: 5 to 10 minutes daily, especially in the evening or whenever the mind is scattered. Keep the sound gentle if there is ear discomfort, sinus pressure, or headache.

Sequence 2: Sitali or Sitkari Pranayama (Cooling Breath) for Pitta-Type Anxiety

Sitali is the classical cooling pranayama in which air is drawn in through the tongue and released through the nostrils. The Hatha Yoga tradition describes Sitali and Sitkari among the major pranayama practices and associates them with cooling, thirst-reducing, and Pitta-pacifying effects. In an Ayurvedic anxiety protocol, this makes Sitali most appropriate when the anxious state feels hot, sharp, irritated, impatient, flushed, or headache-prone.

Best for: Pitta-type anxiousness with irritability, heat, impatience, intensity, burning sensation, flushed face, or anger-tinged worry.

Practice: Sit upright. Curl the tongue into a tube if possible. Inhale slowly through the rolled tongue as if sipping cool air. Close the mouth and exhale gently through both nostrils. If the tongue does not curl, practice Sitkari: lightly bring the teeth together, part the lips, inhale through the teeth with a soft hissing sensation, then close the mouth and exhale through the nostrils. Practice 10 to 15 rounds, then return to natural nasal breathing.

Duration: 5 to 10 minutes, preferably during the hotter part of the day or after emotionally heated work. Avoid the practice in cold weather, chills, active cough, significant congestion, or cold-triggered asthma unless guided by a qualified teacher or clinician.

Sequence 3: Kapalabhati (Skull-Shining Cleansing Breath) for Kapha-Type Heaviness

Kapalabhati is listed in the Hatha Yoga tradition as one of the cleansing practices. It uses repeated active exhalations with passive inhalations, making it more stimulating than the calming practices above. It is best reserved for Kapha-type heaviness: dullness, morning fog, lethargy, sluggishness, and a congested feeling in the body and mind. It is not the first choice for panic, insomnia, heat, irritability, pregnancy, uncontrolled hypertension, or fragile health.

Best for: Kapha-type low mood with heaviness, lethargy, brain fog, excess sleepiness, dull breath, and morning inertia.

Practice: Sit upright on a chair or cushion. Take one natural inhale. Exhale sharply through the nose by drawing the lower abdomen inward. Allow the inhale to return passively as the abdomen releases. Keep the chest, shoulders, face, and throat relaxed. Begin with 20 to 30 gentle pumps, then rest for 60 seconds with normal breathing. Repeat for 2 to 3 rounds only if there is no dizziness, pressure, or strain.

Duration: 2 to 5 minutes in the morning, 3 to 5 days per week. Stop immediately if you feel lightheaded, pressured in the head or eyes, breathless, or anxious. This practice should be learned directly from a qualified yoga therapist or teacher if you are new to pranayama.

Sequence 4: Sama Vritti Pranayama (Equal-Ratio Breathing) for Mixed Anxiety

Sama Vritti means an even or equal pattern. In its simplest form, inhalation and exhalation are made equal; in more advanced forms, gentle pauses are added. The value of this practice is its neutrality: it is neither strongly heating nor strongly cooling, neither forceful nor sedating. It is useful when the anxious state is mixed, situational, or performance-related and you need a steady rhythm before speaking, working, driving, or sleeping.

Best for: Mixed-dosha stress, performance anxiety, work pressure, mental scatteredness with mild heat, and general daily regulation.

Practice: Sit upright. Inhale through the nose for 4 counts and exhale through the nose for 4 counts. Continue until the breath becomes smooth. If comfortable, progress to 5–5 or 6–6. Only after the practice is easy, add light pauses: inhale 4, pause 2, exhale 4, pause 2. Breath retention is optional and should remain soft.

Duration: 5 to 15 minutes at any time of day. Omit breath holds during pregnancy, uncontrolled blood pressure, panic tendency, significant cardiovascular disease, or any situation where holding the breath creates strain.

Sequence 5: Chandra Bhedana (Moon-Piercing Breath) for Night Anxiety

Chandra Bhedana is a left-nostril inhalation and right-nostril exhalation pattern used in yoga practice for a cooling, quieting effect. In the language of nadi theory, the left side is associated with Ida Nadi, the lunar current, while the right side is associated with Pingala Nadi, the solar current. For practical use, it is a simple, low-intensity sequence for bedtime anxiousness, heated thoughts, and difficulty shifting from activity into rest.

Best for: Night-time anxiety, sleep-onset worry, heat with mental activity, and acute overstimulation when forceful breathing would be inappropriate.

Practice: Sit comfortably or recline with the head slightly elevated. Use the right hand in a simple nostril-control position. Close the right nostril with the thumb and inhale slowly through the left nostril. Close the left nostril with the ring finger, release the right nostril, and exhale through the right nostril. Keep the breath quiet, smooth, and unforced. Repeat for 5 to 10 minutes.

Duration: 5 to 10 minutes before sleep. Avoid breath retention. Skip this practice when the nose is blocked, when left-nostril breathing feels effortful, or when lying flat worsens reflux or breathing symptoms.

Sequence Selection by Dosha and Anxiety Type

Use the table as a quick decision guide. The safest rule is to choose the gentlest practice that matches the dominant quality: quiet Vata with sound and steadiness, cool Pitta with Sitali or Sitkari, mobilize Kapha with careful cleansing breath, balance mixed stress with equal breathing, and use Chandra Bhedana for night-time downshifting.

Herbs That May Support a Pranayama Routine

Herbs are not required for pranayama, but classical Ayurveda often pairs breath, diet, sleep, daily routine, and selected medhya or respiratory-supportive herbs when a person needs broader support. Herb choice should be individualized by constitution, digestion, medications, pregnancy status, and diagnosis.

• Brahmi (Bacopa monnieri): Traditionally used as a medhya herb to support intellect, memory, and clarity. It is best considered when the anxious pattern includes poor concentration and mental fatigue.
• Shankhpushpi (Convolvulus pluricaulis): Traditionally described as a Medhya Rasayana and used in formulations aimed at mental calm, memory, and sleep support.
• Ashwagandha (Withania somnifera): A classical root drug used as a strengthening and restorative herb. It is more appropriate for depletion and stress exhaustion than for hot, inflamed, or highly Pitta states.
• Vacha (Acorus calamus): A sharp, heating classical herb used in Ayurveda for Kapha-type obstruction and mental dullness. It requires professional guidance and proper processing; it should not be self-prescribed.
• Tulsi (Ocimum sanctum / Ocimum tenuiflorum): Traditionally used for respiratory support and as a household herbal infusion. A mild tulsi tea may suit Kapha-type congestion, but it can be too heating for some Pitta-dominant people.

Sequencing Your Practice: A Weekly Template

A useful weekly template is to begin with observation rather than routine. On waking, ask: Is the mind racing, hot, heavy, or simply pressured? If the morning feels restless and ungrounded, choose Bhramari. If it feels hot and irritable, choose Sitali or Sitkari. If it feels heavy and dull, choose a short, careful Kapalabhati practice followed by quiet breathing. If the state is mixed, use Sama Vritti. At night, choose Bhramari or Chandra Bhedana rather than stimulating practices.

For a balanced week, practice one primary sequence for 5 to 10 minutes daily for seven days before switching. This gives the body enough repetition to respond and gives you a clearer sense of which doshic pattern is dominant. Avoid stacking many pranayamas in one sitting unless guided; one well-matched practice done consistently is better than a complicated routine performed with strain.

Actionable Tip: Tonight, set a 10-minute timer before sleep. Practice either Bhramari or Chandra Bhedana with no breath retention and no force. If your anxiety is restless and thought-heavy, choose Bhramari. If it is hot, wired, or sleep-resistant, choose Chandra Bhedana. Repeat the same practice for seven nights and observe sleep onset, morning calmness, and any signs of strain.

Nothing in this article diagnoses or treats a medical condition. Use it as educational information and consult a qualified Ayurvedic practitioner, yoga therapist, physician, or mental health provider before starting herbs, supplements, detoxes, or therapeutic breathwork protocols, especially if pregnant, managing a condition, or taking medication.

References

1. Sacred-texts (sacred-texts.com)
2. Charaka Samhita — Vata dosha
3. Charaka Samhita — Pranavaha srotas
4. Breathwork Interventions for Adults with Clinically Diagnosed Anxiety Disorders: A Scoping Review (2023), PubMed Central
5. Nature (nature.com)
6. Effect of breathwork on stress and mental health: A meta-analysis of randomised-controlled trials (2023), PubMed
7. Brief structured respiration practices enhance mood and reduce physiological arousal (2023), PubMed
8. Cell (cell.com)
9. Effects of Slow Breathing Exercises on Cardiac Autonomic Functions in Anxiety Disorder-A Randomised Control Trial (2024), PubMed
10. Effect of Bhramari Pranayama intervention on stress, anxiety, depression and sleep quality among COVID 19 patients in home isolation (2022), PubMed
11. Immediate Effects of Bhramari Pranayama on Resting Cardiovascular Parameters in Healthy Adolescents (2016), PubMed Central
12. Humming greatly increases nasal nitric oxide (2002), PubMed
13. Mayoclinic (mayoclinic.org)
14. The impact of cold on the respiratory tract and its consequences to respiratory health (2018), PubMed Central
15. Yogainternational (yogainternational.com)
16. Study of immediate neurological and autonomic changes during kapalbhati pranayama in yoga practitioners (2022), PubMed Central
17. Saspublishers (saspublishers.com)
18. Yogajournal (yogajournal.com)
19. Ijcep (ijcep.org)
20. Ayurvedic Pharmacopoeia of India
21. An update on Ayurvedic herb Convolvulus pluricaulis Choisy (2014), PubMed Central
22. Ayurvedic Pharmacopoeia of India
23. Ssgcbams (ssgcbams.co.in)
24. Ia800501 (ia800501.us.archive.org)
25. Ijrap (ijrap.net)
26. Tulsi – Ocimum sanctum: A herb for all reasons (2014), PubMed Central

Anxiety can feel like a racing heart, restless thoughts, difficulty sleeping, tightness, worry that will not settle, or a sense of being unable to return fully to the body. In Ayurvedic language, this “wired but ungrounded” state is often approached through the lens of aggravated Vata, the dosha associated with movement, change, dryness, lightness, coldness, subtlety, and instability.

This does not mean every experience of anxiety is only Vata, or that Ayurveda replaces mental health care. It means Ayurveda offers a practical map for restoring steadiness: add warmth where there is coldness, oiliness where there is dryness, routine where there is irregularity, and weight where there is lightness. The grounding protocol below keeps that simple principle at the center.

Why Ayurvedic Grounding Works for Vata-Type Anxiety

Ayurveda works through qualities. The classical principle of Samanya-Vishesha teaches that similarity increases and dissimilarity decreases. When Vata is high, more speed, cold food, skipped meals, overstimulation, late nights, and constant movement tend to push the same pattern further. Grounding works by bringing in the opposite qualities: warm, steady, moist, slow, rhythmic, nourishing, and embodied.

This is where Prithvi, the earth element, becomes useful as a practical image. Earth expresses structure, heaviness, firmness, density, and stability. A Vata-grounding routine does not try to suppress movement; it gives movement a stable base. The five practices below do that through touch, food, sensory awareness, nasal care, and breath.

The Five Grounding Practices

These practices are best understood as a daily rhythm rather than emergency tricks. Use them gently and consistently, and adapt them to your constitution, season, climate, age, strength, medical history, and guidance from a qualified practitioner.

1. Abhyanga: Daily Warm Oil Self-Massage

Abhyanga means oil massage. In the daily routine described in Ashtanga Hridaya, abhyanga is praised for relieving excess Vata, tiredness, dryness, and supporting sleep, nourishment, skin quality, and strength. The text gives special emphasis to the head, ears, and feet, which makes this practice especially relevant when the mind feels scattered and the body feels tense or disconnected.

For a simple Vata-grounding version, warm a small bowl of sesame oil or another oil selected for your constitution. The oil should feel pleasantly warm on the inner wrist, never hot. Apply it slowly over the body, using long strokes over the limbs and circular strokes over the joints. Give extra time to the soles of the feet, the calves, the lower back, the shoulders, the scalp, and the area behind the ears.

Let the oil remain for 10 to 20 minutes, then bathe with warm water. Keep the bathroom warm and avoid rushing afterward. Abhyanga is traditionally avoided when there is strong Kapha aggravation, soon after purification therapies, or during indigestion. Anyone with skin disease, fever, acute illness, pregnancy, recent surgery, or a complex medical condition should use it only with professional guidance.

2. Barefoot Ground Awareness

Barefoot ground awareness is a simple way to bring attention down from the head into the feet. Ayurveda lists the lower body, including the legs, among important Vata regions, and a slow foot-centered practice gives the moving mind a concrete sensory anchor. This is not a claim that the earth alone treats anxiety; it is a deliberate practice of contact, steadiness, and attention.

Choose a safe natural surface such as clean grass, soil, or sand. Walk slowly for 10 to 20 minutes, feeling the heel, arch, ball of the foot, and toes. Let the breath remain easy. Do not turn it into cardio, speed walking, or a productivity task. The point is to feel weight, pressure, temperature, texture, and contact. If outdoor conditions are unsafe, stand on a firm mat indoors and press the soles evenly into the floor while breathing slowly.

3. Warm, Cooked, Unctuous Meals

Food can either continue the Vata pattern or help reverse it. For Vata, Ayurveda generally favors warm, cooked, moist, gently oily, nourishing meals and reduces overreliance on cold, raw, dry, very light, irregular, or rushed eating. This is why soups, stews, rice dishes, cooked grains, root vegetables, ghee, sesame oil, and simple kitchari are classical-style choices for grounding.

A practical plate might include rice, oats, wheat, or another well-cooked grain; cooked carrots, beets, pumpkin, squash, or sweet potato; mung dal or another suitable protein; and a small amount of ghee or oil. Eat seated, without multitasking, and chew well. Ayurveda also emphasizes eating after the previous meal has digested and taking food in a measured quantity. For anxious Vata, regular mealtimes are often as important as the menu itself.

Begin with one reliable cooked meal every day if your schedule is chaotic. Then build toward two. Avoid making iced drinks, dry snacks, raw salads, meal skipping, and late-night grazing the center of your routine. The body learns safety through repetition: warm food, predictable timing, and enough nourishment.

4. Nasya: Gentle Nasal Oil Application

Nasya is the Ayurvedic practice of administering medicine or medicated oil through the nostrils. Classical teaching treats the nose as a doorway to the head, and nasya is traditionally used for conditions of the head, neck, and sense organs. For a grounding routine, this should be kept gentle and conservative, especially for home use.

With guidance from a qualified Ayurvedic practitioner, a mild pratimarsha nasya approach may use two drops of suitable oil in each nostril. Anu Taila is a classical medicated oil used for nasya, while plain sesame oil may be used in some simple routines when appropriate. Lie back with the head slightly supported, apply the drops, sniff gently, and remain still for a few minutes.

Nasya is a therapeutic route, not just a wellness trend. Do not force it if it causes burning, coughing, headache, nausea, irritation, or discomfort. Avoid self-prescribing stronger nasya procedures, large doses, or medicated oils without professional supervision. People who are pregnant, managing chronic sinus disease, bleeding disorders, acute infection, neurological conditions, or taking regular medication should seek individualized advice first.

5. Nadi Shodhana Pranayama: Alternate Nostril Breathing

Nadi Shodhana, or alternate nostril breathing, is a pranayama practice in which the breath is directed through one nostril at a time. For Vata-type anxiety, keep the method soft, quiet, and non-competitive. The goal is not to hold the breath aggressively; the goal is to make the breath smooth, even, and steady.

Sit comfortably with the spine upright. Close the right nostril with the right thumb and inhale through the left nostril for a count of 4. Close the left nostril with the ring finger, release the right nostril, and exhale through the right for a count of 6 to 8. Inhale through the right for 4, switch sides, and exhale through the left for 6 to 8. This completes one cycle.

Practice 6 to 10 cycles once daily. Let the exhale be longer than the inhale only if it feels natural. If breath retention increases agitation, skip retention completely. Stop if you feel dizzy, strained, panicky, short of breath, or uncomfortable. Done gently, this practice gives the restless mind one clear rhythm to follow.

Building the Protocol Into Your Life

Do not begin with all five practices at full intensity. Start with the two that are easiest to repeat: warm oil massage and alternate nostril breathing are often the most practical starting pair. Add warm cooked meals next, then barefoot ground awareness, then nasya if it is appropriate for you.

A simple morning routine could look like this: wake at a steady time, drink something warm, complete elimination and hygiene, do 6 cycles of Nadi Shodhana, apply warm oil to the feet and body, bathe, and eat a warm breakfast. A simple evening version could include a cooked dinner, a short barefoot or floor-awareness practice, oil on the soles of the feet, and a few quiet breathing cycles before bed.

The deeper medicine here is rhythm. Vata is disturbed by irregularity and steadied by repetition. A grounded life is built from small signals repeated daily: warm touch, warm food, slower breath, safe contact, and predictable timing. These practices do not erase stress from life. They give the body and mind a steadier place from which to meet it.

Nothing in this article diagnoses, treats, or cures anxiety or any medical condition. Use it as educational information and consult a qualified Ayurvedic practitioner, physician, or mental health professional before starting herbs, medicated oils, detoxes, breath-retention practices, or therapeutic protocols, especially if pregnant, managing a condition, taking medication, or experiencing severe anxiety, panic, depression, trauma symptoms, or thoughts of self-harm.

References

1. Mayoclinic (mayoclinic.org)
2. NHS
3. NCCIH
4. Ayurveda-online (ayurveda-online.net)
5. Universal significance of the principle of Samanya and Vishesha beyond Ayurveda (2018), PubMed Central
6. Charaka Samhita — Samanya Vishesha Theory
7. Ask-ayurveda (ask-ayurveda.com)
8. Easyayurveda (easyayurveda.com)
9. Easyayurveda (easyayurveda.com)
10. Banyanbotanicals (banyanbotanicals.com)
11. Banyanbotanicals (banyanbotanicals.com)
12. Ayurveda (ayurveda.com)
13. Easyayurveda (easyayurveda.com)
14. Easyayurveda (easyayurveda.com)
15. Yogainternational (yogainternational.com)
16. Banyanbotanicals (banyanbotanicals.com)
17. Slow breathing for reducing stress: The effect of extending exhale (2023), PubMed Central
18. The relaxation effect of prolonged expiratory breathing (2018), PubMed Central

This captures the present state of Shankhpushpi research: a credible preclinical signal and a modern pharmacopoeial identity, but major uncertainty about species, extract composition, mechanism, human dosing, interactions, and effectiveness for diagnosed anxiety disorders.

The Identity Problem: Which Plant Is Shankhpushpi?

The first research question is botanical, not pharmacological. “Shankhpushpi” has been applied to more than one plant in Indian practice and commerce. A comparative pharmacognostic investigation published in 2010 documented four plants traditionally traded or used under the name:

• Convolvulus pluricaulis Choisy (Convolvulaceae)
• Evolvulus alsinoides L. (Convolvulaceae)
• Clitoria ternatea L. (Fabaceae)
• Canscora decussata (Roxb.) Schult. (Gentianaceae)

These names are not interchangeable experimental labels. The 2010 study compared morphology, microscopy, physicochemical constants, and chromatographic fingerprints to support authentication. A paper or product that says only “Shankhpushpi” may therefore be impossible to reproduce reliably.

The Ayurvedic Pharmacopoeia of India, Part I, Volume II, defines Shankhapushpi as the dried whole plant of Convolvulus pluricaulis Choisy. Its monograph describes a prostrate or sub-erect, spreading, hairy perennial herb with a woody rootstock. The same monograph notes that Clitoria ternatea and Evolvulus alsinoides are used as Shankhapushpi in certain parts of India. Thus, the pharmacopoeia supplies a reference identity while also acknowledging regional substitution.

A 2016 study developed an internal-transcribed-spacer multiplex PCR assay to distinguish Convolvulus prostratus—the name used by those authors for the plant also cited as C. pluricaulis—from E. alsinoides. It generated species-specific products of 200 and 596 base pairs and detected 10% admixture. Molecular testing is useful, but trials still need documented sourcing, voucher specimens, and chemical standardization.

Classical and Pharmacopoeial Profile

In the Charaka Samhita tradition, Shankhapushpi is grouped with Mandukaparni, Yashtimadhu, and Guduchi in medhya rasayana practice. “Medhya” concerns intellect, memory, and mental faculties within Ayurveda; it is not automatically a claim to treat generalized anxiety disorder, dementia, or another modern diagnosis.

The official pharmacopoeial monograph gives the following attributes for Convolvulus pluricaulis. These are the API entries and should not be replaced with properties copied from a different regional substitute or later secondary source:

The API lists manasaroga and apasmara among therapeutic uses and gives 3–8 g of powder as the monograph dose. These categories are not exact synonyms for contemporary anxiety disorders or epilepsy and require qualified clinical interpretation.

What the Anxiety Studies Actually Show

The evidence most often cited for anxiety consists mainly of rodent experiments. These studies can identify a behavioural signal and guide mechanism research, but they cannot determine whether an authenticated product is effective, safe, or appropriately dosed for a person with an anxiety disorder.

Open-arm time is a behavioural proxy, not a direct measure of calmness, receptor occupancy, or therapeutic equivalence. The extract also lacked a quantified marker specification. Because different botanical sources produce different CNS profiles, future trials should report the Latin binomial, plant part, solvent, extraction ratio, voucher specimen, contaminant testing, fingerprint, and marker range.

GABAergic Activity: A Plausible Pathway, Not a Settled Human Mechanism

The 2014 paper proposed possible involvement of the GABA-benzodiazepine system, but it did not measure receptor binding, chloride flux, or human GABA-A activity. Claims of proved benzodiazepine-site agonism or benefit without tolerance go beyond its evidence.

The 2017 ethanol-withdrawal experiment provides more specific preclinical support. In that mouse model, the anti-anxiety-like effect was blocked by a GABA-A antagonist, and chronic administration was associated with increased cortico-hippocampal GABA. This supports GABA-A involvement under the conditions of that experiment. It does not establish GABA-A as the sole mechanism of every preparation or predict the size of an effect in human anxiety.

Reviews report alkaloids, coumarins, flavonoids, and phytosterols in C. pluricaulis, including shankhpushpine, convolamine, scopoletin, kaempferol, and beta-sitosterol. Presence does not establish mechanism, and content varies with identity and extraction. The API gives only the broad constituent entry “alkaloid,” not a clinical standard for anxiety.

Mechanistic caution: A 2022 network-pharmacology paper predicted multiple targets and pathways relevant mainly to dementia research. Computational target mapping is hypothesis-generating. It cannot confirm that a compound reaches the human brain at an active concentration, binds the predicted target in vivo, or improves a clinical outcome.

Cognition and Memory: Promising Preclinical Data, Limited Clinical Proof

The cognition literature remains dominated by laboratory models. Rodent studies report effects after scopolamine- or aluminium-associated impairment. In one aluminium-neurotoxicity model, C. pluricaulis affected muscarinic M1 receptor, choline acetyltransferase, and NGF-TrkA expression. These findings do not establish prevention or treatment of human dementia.

Another rodent study used piracetam as a reference in learning and memory tests. A reference group does not establish clinical equivalence, and animal performance cannot be turned into a prescribing comparison.

Human evidence is modest. A 2015 comparative study enrolled 102 healthy young volunteers and evaluated four 500 mg Shankhapushpi tablets twice daily after food with milk for two months against a programme involving yoga and Satvavajaya Chikitsa. Some memory measures improved, but the herbal intervention was not tested against an inert placebo under a fully blinded design, and the participants did not have anxiety disorders or dementia. The study therefore offers preliminary information about cognitive testing, not proof of treatment for a psychiatric or neurodegenerative condition.

An Alzheimer’s Drug Discovery Foundation evidence review likewise concluded that well-controlled human data are lacking. Comparative trials have not established superior safety or efficacy over prescription drugs.

Dose and Preparation: What Can Be Stated Reliably

Mouse doses should not be converted into self-treatment doses by simple body-surface-area arithmetic. Such calculations do not account for extract ratio, constituent exposure, metabolism, product quality, or indication.

A useful label states the botanical name, plant part, crude-drug equivalent, solvent and ratio, and batch testing. “Shankhpushpi 500 mg” is incomplete when products may contain powder, concentrated extract, or another species.

Safety and Herb–Drug Interactions

Human safety information is insufficient for confident claims about long-term use or combinations with psychiatric and neurological medicines. Traditional use cannot replace adverse-event monitoring and interaction studies.

• Phenytoin: A 1992 report described two patients who lost seizure control while using a Shankhapushpi preparation with phenytoin. Repeated administration in rats reduced phenytoin concentration and anticonvulsant activity. Although botanical authentication was inadequate by current standards, patients should not combine them without the prescribing clinician.
• Benzodiazepines, sedating antihistamines, alcohol, and other CNS depressants: Some extracts show CNS-depressant or sleep-potentiating activity in animals. Additive drowsiness is a reasonable precaution, although human risk is unquantified.
• Antihypertensive treatment: Limited summaries note possible blood-pressure-lowering effects. A person with low blood pressure or prescribed antihypertensives should seek clinical advice and monitoring rather than assuming the combination is harmless.
• SSRIs, SNRIs, and other antidepressants: Computational literature does not establish a clinical serotonin-syndrome interaction. Combination safety is inadequately studied.
• Pregnancy, breastfeeding, children, liver or kidney disease: Adequate controlled safety data are lacking. Unsupervised medicinal use should be avoided in these groups unless an appropriately qualified clinician has assessed the individual situation.

Safety advice: Do not stop or replace prescribed anxiety, seizure, sleep, or blood-pressure treatment with Shankhpushpi. Discuss the exact product with the prescribing healthcare provider and a qualified Ayurvedic practitioner, especially when symptoms are severe or medicines are already used.

Research Gaps That Should Shape the Next Trial

The evidence does not show that Shankhpushpi “works like a benzodiazepine.” It shows that authenticated C. pluricaulis deserves better-designed human research addressing the following gaps.

1. Diagnosed anxiety populations: PubMed-indexed literature does not provide an adequately powered, double-blind, placebo-controlled trial of authenticated C. pluricaulis for a defined anxiety disorder.
2. Botanical authentication: Trials need a voucher specimen and molecular or validated pharmacognostic confirmation, not only the common name Shankhpushpi.
3. Chemical standardization: Extract ratio, solvent, fingerprint, marker range, contaminants, pesticides, microbes, and heavy metals should be reported batch by batch.
4. Pharmacokinetics: Human absorption, active metabolites, brain exposure, half-life, and dose proportionality have not been established for a clinically standardized preparation.
5. Safety and interactions: Studies should prospectively monitor sedation, cognition, blood pressure, liver and kidney indices, withdrawal effects, and interactions with commonly prescribed medicines.
6. Clinically meaningful outcomes: A future trial should use a preregistered primary anxiety scale, functional outcomes, adverse-event reporting, and follow-up after discontinuation rather than relying only on laboratory memory tests or subjective impressions.

Where the Evidence Leaves Us

Shankhpushpi has a genuine Ayurvedic context, an API monograph for Convolvulus pluricaulis, and anxiolytic-like and cognitive signals in animal models. That justifies investigation, not a percentage comparison with diazepam, confirmed GABA-A agonism in people, or replacement of evidence-based anxiety care.

A defensible next step is a preregistered, randomized, double-blind, placebo-controlled study using authenticated, chemically characterized C. pluricaulis, preceded by dose-finding and safety work. Until then, species verification, professional supervision, medication review, and honest uncertainty are more appropriate than promotional certainty.

References

1. Openneurologyjournal (openneurologyjournal.com)
2. Neuropharmacological Profile of Extracts of Aerial Parts of Convolvulus pluricaulis Choisy in Mice Model (2014), PubMed
3. Comparative pharmacognostical investigation on four ethanobotanicals traditionally used as Shankhpushpi in India (2010), PubMed
4. Comparative pharmacognostical investigation on four ethanobotanicals traditionally used as Shankhpushpi in India (2010), PubMed Central
5. Ayurvedic Pharmacopoeia of India
6. Nootropic herbs (Medhya Rasayana) in Ayurveda: An update (2012), PubMed Central
7. Internal transcribed spacer guided multiplex PCR for species identification of Convolvulus prostratus and Evolvulus alsinoides (2016), PubMed Central
8. Tandfonline (tandfonline.com)
9. Nootropic, anxiolytic and CNS-depressant studies on different plant sources of shankhpushpi (2011), PubMed
10. Effect of Shankhpushpi on Alcohol Addiction in Mice (2017), PubMed Central
11. Frontiersin (frontiersin.org)
12. Protective Mechanisms of Nootropic Herb Shankhpushpi (Convolvulus pluricaulis) against Dementia: Network Pharmacology and Computational Approach (2022), PubMed Central
13. In vivo investigation of the neuroprotective property of Convolvulus pluricaulis in scopolamine-induced cognitive impairments in Wistar rats (2011), PubMed Central
14. Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain (2009), PubMed
15. Nootropic efficacy of Satvavajaya Chikitsa and Ayurvedic drug therapy: A comparative clinical exposition (2015), PubMed
16. Alzdiscovery (alzdiscovery.org)
17. Analysis of a clinically important interaction between phenytoin and Shankhapushpi, an Ayurvedic preparation (1992), PubMed

Nothing in this article diagnoses or treats a medical condition. Use it as educational information and consult a qualified Ayurvedic practitioner or physician before starting herbs, supplements, detoxes, or therapeutic protocols, especially if pregnant, managing a condition, or taking medication.

Pranayama gives that signal through the breath. In Ayurveda-informed self-care, yogic breathing is commonly used as a practical support for calming prana, settling the mind, and reducing the speed and intensity of stress responses. Modern physiology describes the same practice in terms of respiratory rhythm, heart-rate variability, vagal modulation, and the shift from sympathetic arousal toward parasympathetic recovery.

The three practices below are simple enough to use during acute anxiety: at your desk, before a meeting, in a parked car, or at night when the mind will not settle. Each can be done in about one to two minutes. Keep the breath gentle. If a technique makes you dizzy, strained, panicky, or breath-hungry, stop and return to normal breathing.

Exercise 1: Nadi Shodhana (Alternate Nostril Breathing)

Best for: racing thoughts, mental restlessness, and the “monkey mind” pattern where attention jumps from one worry to another.

Time required: 90 seconds to 2 minutes, or about 6 to 8 complete cycles.

The technique:

1. Sit upright with the shoulders relaxed. Close your eyes if the environment is safe and appropriate.
2. Bring your right hand to your face. Use the right thumb to close the right nostril and the right ring finger to close the left nostril. The index and middle fingers may rest lightly between the eyebrows or curl toward the palm.
3. Close the right nostril and inhale gently through the left nostril for a count of 4.
4. Close the left nostril, release the right nostril, and exhale through the right nostril for a count of 4 to 6.
5. Inhale through the right nostril for a count of 4.
6. Close the right nostril, release the left nostril, and exhale through the left nostril for a count of 4 to 6.
7. That is one complete cycle. Repeat 6 to 8 cycles.

Why it works: The mind is given a precise, repetitive sequence to follow: left, right, right, left. This replaces scattered rumination with a simple breath rhythm and hand pattern. In yogic language, Nadi Shodhana is a balancing practice for ida and pingala, the lunar and solar currents of the subtle body. In practical terms, the slow nasal rhythm helps reduce breath speed and supports autonomic steadiness.

For acute anxiety, begin without breath retention. Classical and advanced forms of Nadi Shodhana may include kumbhaka or breath holding, but holds can feel uncomfortable during panic or breath sensitivity. Add only a natural one-second pause after inhaling or exhaling if it feels easy. Longer retention should be learned from a qualified yoga teacher or practitioner.

When to use it: before a stressful meeting, before a difficult phone call, after too much screen stimulation, or whenever thoughts start spiraling faster than you can sort them.

Exercise 2: Extended Exhale Breathing (Dirgha Rechaka Practice)

Best for: physical anxiety symptoms such as chest tightness, rapid heartbeat, shallow breathing, and the feeling of pressure around the sternum.

Time required: 60 to 90 seconds, or about 5 to 6 breath cycles.

The technique:

1. Sit, stand, or lie down. Keep the jaw, abdomen, and shoulders soft.
2. Inhale through the nose for a count of 4.
3. Exhale through the nose for a count of 6.
4. If the 6-count exhale is comfortable, gradually extend the exhale to a count of 8.
5. Repeat for 5 to 6 cycles. Do not force the exhale or squeeze the breath out.

Why it works: During breathing, heart rate naturally tends to rise slightly with inhalation and fall slightly with exhalation. A longer, smoother exhale spends more time in the downshifting part of the respiratory cycle. This makes the practice especially useful when anxiety is felt in the body rather than only in thought.

In Ayurvedic terms, anxious states that feel fast, restless, tremulous, dry, scattered, or ungrounded are often approached as Vata-aggravated patterns. A slow, steady exhale is grounding because it reduces speed and gives the body a predictable rhythm. For many people, this is the most direct breath practice for calming an activated body.

When to use it: during a panic spike, while lying in bed unable to sleep, before entering a tense conversation, or in any situation where the body feels activated but there is no immediate physical threat.

Exercise 3: Bhramari (Humming Bee Breath)

Best for: acute overwhelm, sensory overload, irritability, and anxiety that feels “too loud, too bright, too much.”

Time required: 90 seconds to 2 minutes, or about 5 to 7 cycles.

The technique:

1. Sit comfortably with the spine upright and the face relaxed.
2. Close your eyes. If you are in a private setting, place the index fingers gently on the tragus, the small cartilage flap in front of each ear canal, and lightly close the ears. You can also practice without closing the ears.
3. Inhale through the nose for a count of 4.
4. Exhale with the mouth closed while making a soft, steady humming sound, like a bee. Let the hum last as long as the exhale remains comfortable.
5. Feel the vibration around the face, throat, chest, and skull. Keep the sound low and smooth rather than loud or strained.
6. Repeat 5 to 7 times.

Why it works: Bhramari combines slow nasal exhalation with vibration. The humming gives the mind a sound to rest on, while the vibration creates a strong internal sensory signal that can reduce the pull of external noise and mental agitation. Closing the ears gently increases the inward resonance and makes the practice especially useful when sound, light, and activity feel overwhelming.

Classical yoga describes Bhramari through its bee-like resonance and its pleasing effect on the mind. Modern physiology adds another layer: humming through the nose increases nasal nitric oxide output and improves sinus gas exchange during the humming breath. This does not make Bhramari a cure for anxiety, but it supports its role as a calming nasal breathing practice with a distinct vibrational effect.

When to use it: before public speaking, after distressing news, in a private place during sensory overwhelm, or before bed when the mind refuses to quiet down.

Quick Reference: Which Technique for Which Type of Anxiety

Use the symptom you notice first. If the mind is racing, start with Nadi Shodhana. If the body is tight and the heart is fast, start with the extended exhale. If the world feels too loud or overstimulating, start with Bhramari.

Stacking These With Ayurvedic Herbs for Deeper Support

Breathing practices are best for the immediate spike. Herbs are different: they are not emergency tools, and they should be selected according to constitution, digestion, sleep pattern, medications, age, pregnancy status, and the exact presentation of anxiety. In Ayurveda, persistent anxious restlessness may be discussed under patterns involving disturbed Vata, prana, rajas, sleep disruption, or manasika imbalance. A qualified Ayurvedic practitioner can decide whether herbs are appropriate and which form is safest.

A safe plan is to treat herbs as individualized medicine, not as a generic anti-anxiety stack. Start with the breath practices first. If anxiety is daily, sleep is disturbed, or you are already taking prescription medicines such as SSRIs, benzodiazepines, stimulants, antipsychotics, thyroid medicine, blood-pressure medicine, or diabetes medicine, consult a qualified practitioner or healthcare provider before adding herbs.

Building a Sustainable Anti-Anxiety Practice

These breathing techniques work best when practiced before the crisis as well as during the crisis. The aim is not to suppress emotion; it is to train the body to recognize a calmer rhythm quickly. Two minutes daily is enough to build familiarity.

Here is a practical 4-week plan:

• Week 1: Pick one technique. Practice it twice daily for 2 minutes, once in the morning and once in the evening, whether or not you feel anxious.
• Week 2: Add a second technique. Use one in the morning and one in the evening. Keep the breath gentle and easy.
• Week 3: Add the third technique. Begin matching the practice to the symptom: Nadi Shodhana for racing thoughts, extended exhale for body activation, and Bhramari for overwhelm.
• Week 4 and beyond: Maintain at least one 2-minute breathing session daily. Use extra sessions during acute anxiety, before stressful events, or before sleep.

Anxiety is not a character weakness. It is a body-mind pattern that can become faster than conscious thought. Breath gives you a direct way to slow that pattern down: through the nose, with a count, without force. Small practices done repeatedly are more useful than heroic efforts done only in crisis.

Disclaimer: This content is for informational purposes only and is not a substitute for professional medical, psychiatric, or psychological care. If you experience severe anxiety, panic attacks, self-harm thoughts, trauma symptoms, chest pain, fainting, or anxiety that interferes with daily functioning, consult a licensed healthcare or mental health professional. Herbal supplements can interact with prescription medicines and may not be safe during pregnancy, breastfeeding, liver disease, thyroid conditions, autoimmune disease, or before surgery. Consult a qualified practitioner or healthcare provider before starting any herbal regimen.

References

1. Sacred-texts (sacred-texts.com)
2. Yogajournal (yogajournal.com)
3. Assessment of the effects of pranayama/alternate nostril breathing on the parasympathetic nervous system in young adults (2013), PubMed Central
4. Effect of Alternate Nostril Breathing Exercise on Experimentally Induced Anxiety in Healthy Volunteers Using the Simulated Public Speaking Model: A Randomized Controlled Pilot Study (2017), PubMed Central
5. How Breath-Control Can Change Your Life: A Systematic Review on Psycho-Physiological Correlates of Slow Breathing (2018), PubMed Central
6. Breath of Life: The Respiratory Vagal Stimulation Model of Contemplative Activity (2018), PubMed Central
7. Mdpi (mdpi.com)
8. Do Longer Exhalations Increase HRV During Slow-Paced Breathing? (2024), PubMed
9. Effects of Bhramari Pranayama on health – A systematic review (2018), PubMed Central
10. Blog (blog.anandway.com)
11. Humming greatly increases nasal nitric oxide (2002), PubMed
12. Humming (Simple Bhramari Pranayama) as a Stress Buster: A Holter-Based Study to Analyze Heart Rate Variability (HRV) Parameters During Bhramari, Physical Activity, Emotional Stress, and Sleep (2023), PubMed Central
13. Tele-counselling for management of Chittodvega (anxiety disorder) in Ayurveda–composing ancillary methods during the Covid 19 pandemic (2020), PubMed Central
14. Ayurvedic Pharmacopoeia of India
15. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults (2012), PubMed Central
16. NCCIH
17. Ayurvedic Pharmacopoeia of India
18. NCBI
19. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial (2008), PubMed Central
20. A comparative clinical study on the effect of Tagara (Valeriana wallichii DC.) and Jatamansi (Nardostachys jatamansi DC.) in the management of Anidra (primary insomnia) (2015), PubMed Central
21. An update on Ayurvedic herb Convolvulus pluricaulis Choisy (2014), PubMed Central
22. NCCIH

Jatamansi (Nardostachys jatamansi) is an aromatic Himalayan medicinal plant whose dried rhizome is used in Ayurveda. The Ayurvedic Pharmacopoeia of India describes it as medhya, nidrajanana, varnya, and kushthaghna, and lists traditional applications that include anidra and manasaroga. These terms support its established Ayurvedic role in preparations intended for sleeplessness, mental disturbance, complexion, and certain skin conditions.

Modern laboratory and animal investigations have examined Jatamansi in relation to sleep, cognition, neuronal injury, seizures, and hair growth. Human investigation is much smaller and does not justify treating the herb as a replacement for psychiatric, neurological, or sleep medication. Its medical use also has an ecological dimension because the slow-growing Himalayan species is threatened by destructive rhizome collection and regulated in international trade.

Botanical Identity and Conservation Status

The accepted botanical name is Nardostachys jatamansi (D.Don) DC. Modern taxonomy places the species in the Caprifoliaceae family, within the valerian subfamily, while older pharmacopoeial and botanical references classify it under Valerianaceae. It is a perennial herb of Himalayan subalpine and alpine environments. The Ayurvedic Pharmacopoeia describes plants 10–60 cm high growing at approximately 3,000–5,000 metres.

The medicinal rhizome is dark brown, strongly aromatic, and covered by reddish-brown fibres formed from the remains of old leaf bases. This fibrous covering gives the underground portion its characteristic matted or hair-like appearance. The pharmacopoeial drug consists specifically of the dried rhizome, although roots and rhizomes are sometimes discussed together in experimental literature and commercial descriptions.

The species is assessed as Critically Endangered on the IUCN Red List. International trade is controlled through CITES Appendix II, where relevant documents may use the name Nardostachys grandiflora, a name treated as synonymous with Nardostachys jatamansi in current botanical databases. Appendix II does not prohibit all trade, but export and import must comply with the applicable permit and sustainability requirements.

Key Botanical and Ayurvedic Details

The following profile reflects the Jatamansi monograph in the Ayurvedic Pharmacopoeia of India rather than unreferenced commercial descriptions.

• Accepted botanical name: Nardostachys jatamansi (D.Don) DC.
• Modern family: Caprifoliaceae; older references use Valerianaceae
• Pharmacopoeial part: Dried rhizome
• Pharmacopoeial synonyms: Mamsi, Jata, and Jatila
• Rasa: Tikta and Kashaya
• Guna: Laghu
• Virya: Shita
• Vipaka: Katu
• Dosha action: Tridoshanut, indicating alleviation of disturbed Vata, Pitta, and Kapha in the appropriate clinical context
• Recorded karmas: Medhya, Varnya, Nidrajanana, and Kushthaghna
• Recorded uses: Kushtha, Daha, Visarpa, Manasaroga, and Anidra

Ayurvedic Pharmacology

Jatamansi is bitter and astringent in taste, light in quality, cooling in potency, and pungent after digestion. The Ayurvedic Pharmacopoeia does not assign Madhura rasa to the drug. Its designation as tridoshanut also does not mean that the same dose or preparation is suitable for every person. Ayurvedic prescribing considers the dominant dosha pattern, digestive capacity, strength, age, season, associated symptoms, and accompanying medicines.

Traditional Uses in Sleep and Mental Health

The pharmacopoeial indications Anidra and Manasaroga provide the clearest official basis for discussing Jatamansi in Ayurvedic sleep and mental-health practice. Anidra denotes disturbed or absent sleep within the Ayurvedic diagnostic framework. Manasaroga is a broad category of disorders involving the mind and should not be translated automatically into one modern diagnosis such as anxiety, major depression, psychosis, or dementia.

In practice, Jatamansi may be selected when sleep disturbance occurs with mental agitation, restlessness, heat-related discomfort, or other features compatible with its cooling and sleep-promoting profile. Some patients instead require treatment directed at pain, breathing disorders, endocrine disease, medication effects, depression, sleep apnoea, or another underlying cause. Persistent insomnia therefore warrants proper clinical assessment rather than indefinite self-treatment with a sedating herb.

The designation medhya distinguishes Jatamansi from a substance used merely to produce dullness. In Ayurvedic reasoning, a medicine may support sleep while also being incorporated into a broader plan for mental function. This traditional position is more precise than claims that the herb has been clinically proven to enhance intelligence or prevent neurodegenerative disease.

Phytochemical Profile

The Ayurvedic Pharmacopoeia identifies essential oil and resinous matter as principal constituents and specifies a minimum volatile-oil content for the crude drug. Modern chemical investigations have reported numerous sesquiterpenes together with coumarins, lignans, neolignans, and other constituents. The exact profile varies with plant material, geographical origin, storage, extraction method, and analytical technique.

• Jatamansone, also called valeranone: A characteristic sesquiterpenoid frequently discussed in pharmacological literature on Jatamansi.
• Nardosinone: A nardosinane-type sesquiterpene examined in neuronal cell models, particularly in experiments involving neurite development.
• Nardostachone: One of several sesquiterpenoid constituents reported from the rhizome.
• Nardal and jatamansic acid: Compounds isolated during phytochemical work that also evaluated hair-growth activity in an animal model.
• Nardin: A constituent isolated from the rhizome in phytochemical investigations.
• Lignans and neolignans: Additional classes documented in chemical studies of Jatamansi roots and rhizomes.

Individual constituents should not be assumed to reproduce the action of the whole pharmacopoeial drug. Conversely, the presence of a compound in a laboratory extract does not establish that ordinary powder, decoction, essential oil, and concentrated capsules have equivalent effects or safety.

Experimental Pharmacology

Most modern work on Jatamansi consists of cell-culture or animal experiments. These investigations help identify possible biological actions, but the extracts, doses, routes of administration, and disease models often differ substantially from ordinary Ayurvedic use in humans.

Sleep and Central Nervous System Activity

An animal study of Jatamansi rhizome powder reported reduced locomotor activity, shorter latency to pentobarbital-induced sleep, and prolonged sleeping time. At the evaluated dose, the preparation did not impair performance in the study’s rotarod and gross-behaviour assessments. These findings support investigation of a central depressant or sleep-facilitating action, but they do not establish a benzodiazepine-like GABA-A mechanism in humans.

Learning and Memory Models

An ethanolic extract was evaluated in mice using learning tasks and experimentally induced amnesia. The extract improved performance in the study and attenuated memory impairment produced by scopolamine, diazepam, and ageing. This is preclinical evidence involving a specific extract and animal doses; it does not establish prevention or treatment of dementia in people.

Experimental Neuroprotection

In a rat model involving 6-hydroxydopamine-induced dopaminergic injury, Jatamansi extract attenuated several behavioural, neurochemical, and oxidative changes associated with the lesion. The model is useful for studying mechanisms related to dopaminergic damage, but it is not equivalent to demonstrating clinical benefit in Parkinson’s disease.

Laboratory investigations have also examined Jatamansi constituents in relation to oxidative stress, inflammation, acetylcholinesterase activity, and experimentally produced neuronal injury. Such observations support continued pharmacological study while remaining distinct from evidence for treating Alzheimer’s disease, Parkinson’s disease, stroke, or other human neurological disorders.

Nardosinone and Neurite Development

Nardosinone has been tested in PC12D neuronal cell models. It enhanced neurite outgrowth induced by nerve growth factor and by certain experimental differentiating agents. In one investigation, nardosinone did not itself act as a direct neurotrophic factor; rather, it enhanced neurite development under stimulated conditions. Claims that it independently generates new nerves in humans go beyond these cell-culture findings.

Seizure Models

An ethanolic root extract increased seizure threshold in a maximal electroshock model in rats but was ineffective against pentylenetetrazole-induced seizures in the same published investigation. The extract also interacted with phenytoin in that model. Results therefore depend on the seizure model and preparation. A person with epilepsy must not add Jatamansi, stop medication, or change an anticonvulsant dose without supervision from the treating neurologist.

Hair-Growth Investigation

A phytochemical study evaluated Jatamansi rhizome extract, fractions, and isolated compounds in an animal hair-growth model. Activity was reported for the tested preparations, providing a basis for further investigation of traditional scalp use. The experiment does not establish a standard treatment for human alopecia, premature greying, autoimmune hair loss, or scarring disorders.

Human Evidence for Insomnia

The principal published human study commonly cited for sleep was a small open comparative trial of Tagara and Jatamansi in primary insomnia. Thirty-four participants were enrolled and thirty completed the trial, with fifteen completing treatment in each group. The Jatamansi group received 4 g of powder with milk three times daily after food for one month. Both groups improved on the study’s sleep assessments, while Tagara produced greater improvement on several reported outcomes.

This investigation was not a placebo-controlled trial of 500 mg twice daily, and it did not report the often-repeated comparison of a 38% PSQI improvement against 12% with placebo. The study dose was also much higher than the general 2–3 g powder dose listed in the Ayurvedic Pharmacopoeia. It should be understood as a small exploratory clinical study, not as a universal dosage protocol.

Claims that Jatamansi has clinically established antidepressant, anti-anxiety, anticonvulsant, cardioprotective, or dementia-preventing effects are not supported by comparable human trials. Its strongest verified position remains its traditional pharmacopoeial use, accompanied by preliminary human sleep data and a wider body of experimental pharmacology.

Evidence Overview

The following table separates pharmacopoeial tradition, human investigation, and experimental findings so that they are not treated as interchangeable forms of evidence.

Pharmacopoeial Preparations and Doses

The Ayurvedic Pharmacopoeia provides reference doses for authenticated crude Jatamansi. These figures are monograph standards, not individualized prescriptions. Concentrated extracts, capsules, essential oils, compound formulations, and products made from a different botanical species cannot be converted directly from the crude-drug dose.

Jatamansi Churna

For the powdered dried rhizome, the pharmacopoeial dose is 2–3 g. The timing, frequency, duration, and accompanying vehicle should be selected by a qualified Ayurvedic practitioner. The much larger regimen used in the small insomnia study should not be copied without clinical supervision.

Jatamansi Decoction

The pharmacopoeial quantity for preparing a decoction is 5–10 g of crude drug. A decoction is not equivalent milligram-for-milligram to dry powder or standardized extract because preparation changes the concentration and range of extracted constituents.

Jatamansyarka

The Ayurvedic Pharmacopoeia names Jatamansyarka as an important formulation containing Jatamansi. Its manufacture and use should follow an authoritative formulary or licensed product specification. A dose for one preparation should not be transferred to another product merely because both carry the name Jatamansi.

Compound Formulations

The composition of similarly named Ayurvedic compound medicines may differ by textual authority, regional tradition, manufacturer, and licensed formula. Consumers should check the complete label rather than assuming that Saraswatarishta, Manasamitra Vatakam, or another mental-health formulation always contains Jatamansi in the same amount. Complex formulations intended for psychiatric or neurological conditions require professional supervision.

Clinical Individualization

Jatamansi is not selected solely from a symptom such as “poor sleep.” Ayurvedic assessment may distinguish sleep disturbance associated with mental overactivity, heat, digestive discomfort, pain, respiratory obstruction, weakness, irregular routine, substance use, or an underlying illness. The same herb may be unsuitable when the cause, constitution, digestive capacity, or medication profile differs.

• Sleep pattern: Difficulty falling asleep, repeated waking, early waking, nightmares, and daytime sleepiness require different assessment.
• Digestive tolerance: Bitter and astringent medicines may be poorly tolerated by some patients or require a carefully selected vehicle.
• Daytime alertness: Sedating effects are undesirable before driving, operating machinery, climbing, or safety-sensitive work.
• Existing diagnoses: Sleep apnoea, bipolar disorder, severe depression, epilepsy, Parkinsonism, dementia, and cardiac symptoms require medical evaluation.
• Concomitant treatment: Prescription medicines, other sedative herbs, alcohol, and cannabis products may alter tolerability or alertness.
• Source of the herb: Conservation status and botanical authenticity should influence whether Jatamansi is selected at all.

Drug Interactions and Safety

Reliable human interaction and long-term toxicity data for Jatamansi are limited. The herb should not be described as free from dependence, cognitive effects, liver effects, or clinically important interactions merely because such outcomes have not been established in controlled trials. Product concentration and authenticity also vary.

Sedatives, Alcohol, and Driving

Because Jatamansi is classified as sleep promoting and has produced central depressant effects in animals, combining it with alcohol, benzodiazepines, barbiturates, opioid pain medicines, sedating antihistamines, antipsychotics, sleep medicines, or other calming herbs may increase drowsiness or impaired coordination. Avoid driving and hazardous work until individual effects are known. Any combination with prescription sedatives should be approved by the prescribing clinician.

Psychiatric and Neurological Medicines

Published data do not establish the specific serotonin-syndrome warning previously attributed to Jatamansi or a clinically proven monoamine-oxidase-inhibiting effect in patients. Even so, people taking antidepressants, antipsychotics, mood stabilizers, anticonvulsants, or Parkinson’s medicines should use it only after medication review. The animal interaction observed with phenytoin is an additional reason not to self-combine Jatamansi with antiseizure therapy.

Pregnancy, Breastfeeding, and Children

Safety during pregnancy and breastfeeding has not been established, so medicinal use is generally avoided unless specifically directed by a qualified healthcare professional. Paediatric use also requires individualized advice. Adult pharmacopoeial doses must never be scaled casually for an infant or child.

Adverse Effects and Medical Review

Possible intolerance may include excessive sleepiness or digestive discomfort, although the frequency of adverse effects has not been defined in large human studies. Stop the product and obtain medical advice for marked confusion, fainting, breathing difficulty, rash, persistent vomiting, worsening mood symptoms, unusual agitation, or seizure activity. Persistent insomnia, palpitations, severe anxiety, or neurological symptoms also require diagnosis rather than repeated self-dosing.

Product Quality

Use a licensed product that identifies the full botanical name, plant part, batch, manufacturer, and recommended dose. Jatamansi may be confused or substituted in commerce with Tagara, now commonly identified as Valeriana jatamansi and historically called Valeriana wallichii. Although both are aromatic Himalayan medicinal plants, they are not interchangeable species. Pharmacopoeial examination, microscopy, and chromatographic identity testing help distinguish authentic material.

As with other Ayurvedic products, poor manufacturing can introduce microbial contamination, pesticides, undeclared pharmaceuticals, or excessive metals. Choosing a reputable manufacturer with appropriate testing is especially important for products intended for prolonged internal use.

Sustainability and Ethical Sourcing

Harvesting the medicinal rhizome usually destroys the plant. Slow regeneration, habitat pressure, and commercial collection have therefore contributed to serious population decline. Conservation is part of clinically responsible use, not merely an optional purchasing preference.

• Prefer documented cultivated material: Cultivation reduces direct pressure on wild populations when the supply chain is genuine and traceable.
• Check legal trade: International shipments should comply with CITES documentation and the laws of the exporting and importing countries.
• Avoid anonymous loose material: Unlabelled rhizomes provide little assurance of species identity, collection method, contamination control, or legal origin.
• Use only when specifically indicated: Routine inclusion in every sleep or relaxation blend increases demand without respecting the herb’s conservation status.
• Consider appropriate alternatives: A practitioner may select another medicine when Jatamansi’s particular Ayurvedic profile is unnecessary.

India’s medicinal-plant programmes include support for conservation, cultivation, and quality planting material for high-priority species such as Jatamansi. Cultivation must still be accompanied by correct botanical identification and suitable high-altitude agricultural practices.

External and Aromatic Use

The strongly aromatic rhizome yields an essential oil used in perfumery and in some external preparations. Jatamansi may also be incorporated into scalp oils, massage oils, or other traditional topical products. External tradition and animal hair-growth experiments do not establish that the essential oil treats human insomnia, alopecia, eczema, psoriasis, or neurological disease.

Head and Scalp Oils

Standardized Jatamansi-containing oils have been described for head-massage applications, and the pharmacopoeial actions Varnya and Kushthaghna provide an Ayurvedic basis for selected skin and cosmetic uses. The oil should be assessed as a complete formulation because the base oil, concentration, processing method, and accompanying herbs affect its properties.

Essential-Oil Precautions

Essential oil is far more concentrated than rhizome powder and should not be swallowed. For skin application it should be suitably diluted in a carrier oil, tested first on a small area, and kept away from the eyes and mucous membranes. Discontinue use if burning, swelling, or dermatitis develops. Diffusion may provide aroma, but a claim of clinically meaningful sedation through inhalation has not been established.

Jatamansi in Ayurvedic Mental-Health Practice

Jatamansi’s verified Ayurvedic descriptors are Medhya and Nidrajanana, with Manasaroga and Anidra among its listed uses. These terms support a traditional role in carefully selected mental-health and sleep formulations. They do not make Jatamansi itself a form of Sattvavajaya; Sattvavajaya is an Ayurvedic psychotherapeutic approach involving regulation of the mind rather than the name of an herbal category.

Herbal treatment is only one part of Ayurvedic care for disturbed sleep or mental distress. Daily routine, diet, sensory regulation, counselling, physical activity, breathing practices, and treatment of contributing disease may all be relevant. Constitutional and dosha assessment can help determine whether Jatamansi fits the patient’s pattern, but it should not delay psychiatric or neurological care when urgent symptoms are present.

Practical Summary

Jatamansi is an authentic Ayurvedic drug with clearly recorded pharmacopoeial properties and uses. Its bitter and astringent taste, light quality, cooling potency, pungent post-digestive effect, Medhya and Nidrajanana actions, and traditional indications for Anidra and Manasaroga are well documented. Experimental investigations provide plausible leads for sleep, cognition, neuronal protection, seizure modulation, and hair growth, while human evidence remains centred on a small open insomnia study.

Responsible use requires three safeguards: accurate botanical identification, medical review of sedating or neurological medicines, and conservation-conscious sourcing. Jatamansi should not replace prescribed treatment for insomnia, anxiety disorders, depression, epilepsy, Parkinson’s disease, dementia, arrhythmia, or any other serious condition.

This article is for educational purposes. Consult a qualified Ayurvedic practitioner and an appropriate healthcare provider before using Jatamansi, particularly during pregnancy or breastfeeding, for a child, or alongside prescription medicines.

References

1. Ia800501 (ia800501.us.archive.org)
2. Powo (powo.science.kew.org)
3. Iucnredlist (iucnredlist.org)
4. Cites (cites.org)
5. National Medicinal Plants Board
6. Comparative and Functional Screening of Three Species Traditionally used as Antidepressants: Valeriana officinalis L., Valeriana jatamansi Jones ex Roxb. and Nardostachys jatamansi (D.Don) DC (2020), PubMed Central
7. Phytochemical investigation and hair growth studies on the rhizomes of Nardostachys jatamansi DC (2011), PubMed Central
8. Central nervous system depressant activity of Jatamansi (Nardostachys jatamansi DC.) rhizome (2020), PubMed Central
9. Nardostachys jatamansi improves learning and memory in mice (2006), PubMed
10. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies (2006), PubMed
11. Nardosinone, the first enhancer of neurite outgrowth-promoting activity of staurosporine and dibutyryl cyclic AMP in PC12D cells (2003), PubMed
12. Nardosinone, a novel enhancer of nerve growth factor in neurite outgrowth from PC12D cells (1999), PubMed
13. Anticonvulsant and neurotoxicity profile of Nardostachys jatamansi in rats (2005)
14. Phytochemical investigation and hair growth studies on the rhizomes of Nardostachys jatamansi DC (2011), PubMed
15. A comparative clinical study on the effect of Tagara (Valeriana wallichii DC.) and Jatamansi (Nardostachys jatamansi DC.) in the management of Anidra (primary insomnia) (2015), PubMed Central
16. Drugs (drugs.com)
17. NCCIH

Anxiety disorders are the world’s most common mental disorders, affecting an estimated 359 million people globally in 2021. Conventional care may include psychological therapies, stress-management skills, mindfulness, and, when appropriate, medicines such as selective serotonin reuptake inhibitors; benzodiazepines are generally not preferred for long-term anxiety care because of dependence risk. Ayurveda offers a complementary framework that looks at anxiety through constitution, doshic imbalance, diet, herbs, breathwork, massage, sleep, routine, and mental discipline.

Understanding Anxiety Through the Lens of Ayurveda

In Ayurvedic practice, anxiety-like states are often discussed under Chittodvega, a state of mental agitation or disturbed steadiness of mind, and within the broader field of Manovikara or mental disturbances. Classical Ayurveda also describes Unmada as a distinct and more severe disorder of mind, intellect, perception, memory, conduct, and behaviour; it should not be equated with ordinary worry or mild anxiety. A careful practitioner therefore assesses the person’s whole pattern rather than treating anxiety as one uniform condition.

Vata aggravation is commonly emphasized because Vata has mobile, light, dry, subtle, and irregular qualities. When these qualities dominate the mind-body system, anxiety may feel like racing thoughts, anticipatory fear, trembling, dry mouth, variable appetite, constipation, light sleep, or difficulty settling. Pitta involvement gives anxiety a sharper, hotter, more driven tone, with irritability, perfectionism, acid reflux, heat sensations, anger-linked worry, and intense dreams. Kapha involvement may appear as heaviness, avoidance, attachment, oversleeping, low motivation, emotional withdrawal, and a slow-moving pattern of worry. Mixed Vata-Pitta anxiety is common when restlessness and irritability alternate. Understanding these distinctions is essential for selecting the right combination of herbs and practices, a process explored further in the clinical dosha assessment guide.

Anxiety Types Mapped to Doshic Patterns

The table below is a practical Ayurvedic map, not a substitute for diagnosis. It helps match common anxiety presentations with dosha-guided herbs, food choices, and daily practices that a qualified practitioner may individualize.

Ayurvedic Herbs for Anxiety and Stress Support

Ayurvedic herbs are selected according to constitution, digestive capacity, strength, age, sleep pattern, medications, and the dominant doshic presentation. The herbs below have both traditional Ayurvedic use and published pharmacological or clinical literature relevant to stress, sleep, cognition, or anxiety-like symptoms. They should be used with professional guidance, especially when prescription medicines, pregnancy, liver disease, thyroid disease, sedation, or complex mental health symptoms are present.

Ashwagandha (Withania somnifera): Stress Resilience and Vata Support

Ashwagandha is a major Rasayana herb used for depleted, stressed, Vata-aggravated presentations where weakness, poor sleep, nervous exhaustion, and reduced resilience are prominent. Human trials of standardized Ashwagandha extracts have reported reductions in stress and anxiety rating scores and cortisol measures, and systematic reviews describe benefit for stress and anxiety while noting that more high-quality research is needed. For practical use, practitioners commonly choose the dose, extract type, and Anupana according to digestion, sleep, body heat, and medication history. For guidance on optimal cycling protocols, see the ashwagandha cycling and breaks protocol.

Jatamansi (Nardostachys jatamansi): Calming the Mind and Supporting Sleep

Jatamansi, also known as Indian spikenard, is used in Ayurveda for mental calmness, sleep support, and unsettled Vata in the mind. Animal research has described anxiolytic-like effects and changes in brain GABA and monoamine neurotransmitter levels after Nardostachys jatamansi extract. Because Jatamansi can be sedating and because the plant is conservation-sensitive in many regions, it should be sourced responsibly and used under the guidance of a qualified practitioner.

Brahmi (Bacopa monnieri): Medhya Support for Cognitive and Emotional Balance

Brahmi is a Medhya Rasayana, traditionally used to support memory, learning, steadiness of mind, and resilience under mental load. Human work with Bacopa monnieri extract has evaluated multitasking stress, mood, cortisol, cognition, anxiety, and depression measures, while preclinical work has examined serotonergic and cholinergic pathways relevant to memory and mood regulation. In anxiety care, Brahmi is especially suited when worry is accompanied by mental fatigue, poor concentration, and emotional reactivity. For a deeper comparison with related nootropic herbs, see the Brahmi vs. Shankhpushpi comparison guide.

Shankhpushpi (Convolvulus pluricaulis): Daytime Calm and Medhya Rasayana

Shankhpushpi is traditionally valued as a Medhya herb for the mind, memory, and emotional steadiness. Pharmacological studies of traditional Shankhpushpi plant sources have described nootropic, anxiolytic, and central-nervous-system effects, with Convolvulus pluricaulis often discussed as an important traditional source. It is commonly chosen for daytime mental calm when clarity is needed rather than heavy sedation.

Tagara (Valeriana wallichii): Anxiety with Insomnia

Tagara is most appropriate when anxious restlessness is closely tied to difficulty falling asleep, disturbed sleep, or frequent waking. In a small comparative clinical study of primary insomnia, Tagara Churna given with milk for one month improved sleep initiation, sleep duration, disturbed sleep, and disturbance in routine work. Valeriana wallichii also contains CNS-active constituents such as 6-methylapigenin, which has been described with sedative, sleep-enhancing, and anxiolytic properties. For comprehensive sleep-focused strategies, see the Ayurvedic sleep remedies guide.

Daily Practices for Anxiety Management

Ayurveda gives daily practices a central place because anxiety is often worsened by irregular timing, overstimulation, poor sleep, unstable meals, and constant sensory input. For Vata-predominant anxiety, the goal is warmth, oiliness, grounding, predictability, and gentle repetition rather than intensity.

Abhyanga (Warm Oil Self-Massage)

Abhyanga is a grounding practice in which warm oil is applied to the body before bathing. Sesame oil is commonly used for Vata presentations, while coconut oil may be preferred when Pitta heat is prominent. A practical home routine uses slow strokes over the limbs, circular motions over the joints, gentle abdominal massage, and quiet rest before a warm shower. A published case report combining Abhyanga and Shirodhara in anxiety described improvement in symptoms and cortisol tracking, but this should be understood as supportive clinical observation rather than a stand-alone treatment claim.

Shirodhara: Continuous Forehead Flow Therapy

Shirodhara involves the steady pouring of warm oil or another prescribed liquid over the forehead for a set period under professional supervision. It is used in Ayurvedic practice for mental restlessness, sleep disturbance, and Vata-Pitta aggravation affecting the mind. Physiological work in healthy volunteers has described a relaxed state with changes in mood and autonomic measures after Shirodhara. A detailed exploration of this therapy is available in the Shirodhara therapy guide.

Pranayama Practices for Anxiety

Nadi Shodhana (Alternate Nostril Breathing): This balancing pranayama is used to steady breath rhythm and reduce sensory agitation. A simple practice is 5-10 minutes of gentle alternate-nostril breathing without strain, breath-holding, or force. It is best practiced seated, with the breath smooth and quiet.

Bhramari (Humming Bee Breath): Bhramari uses a soft humming exhalation to settle agitation and promote a relaxed autonomic state. Human studies of Bhramari have described parasympathetic predominance and reductions in anxiety-related measures in specific populations. It is especially useful when Vata restlessness and Pitta irritability appear together.

Meditation Approaches by Dosha

Meditation is used in Ayurveda and yoga to steady attention, cultivate Sattva, and reduce the grip of repetitive thought. Vata types often benefit from guided body scans, counted breathing, and short repeated sessions. Pitta types often respond well to compassion meditation, cooling imagery, and noncompetitive practice. Kapha types may need walking meditation, mantra repetition, or a brighter morning practice to prevent dullness. For dosha-specific meditation guidance, see the meditation by dosha type guide.

Dietary Modifications for Anxiety

Diet is a major part of Ayurvedic anxiety management because meal timing, temperature, texture, and digestibility directly influence Vata. When anxiety is Vata-predominant, the usual emphasis is on warm, moist, cooked, nourishing foods taken at regular times. Sweet, sour, and salty tastes are traditionally used to pacify Vata, while excessive bitter, astringent, pungent, dry, cold, and irregular eating patterns may worsen Vata qualities.

When Vata is aggravated, favor warm, moist, well-cooked, grounding meals with appropriate sweet, sour, and salty tastes, while reducing cold, dry, raw, and highly irregular eating patterns.

Key dietary guidelines for Vata-predominant anxiety:

• Eat warm, cooked meals at consistent times to reduce irregularity.
• Use healthy fats such as ghee or sesame oil when suitable for digestion and constitution.
• Favor grounding foods such as rice, mung dal, cooked root vegetables, stews, soups, and soft grains.
• Use gentle spices such as cumin, coriander, fennel, cardamom, and small amounts of nutmeg at night when appropriate.
• Reduce excess caffeine, refined sugar, cold drinks, raw salads, dry crackers, and skipped meals.
• Drink warm water or mild herbal teas instead of iced beverages.

Ghee is widely used in Ayurvedic dietetics and medicated Ghrita preparations. Ayurveda also uses the concept of Anupana, the carrier or co-administered substance that helps deliver a medicine in a constitutionally appropriate way. For Vata-type anxiety, practitioners may choose warm milk, ghee, or warm water depending on the herb, digestion, and the person’s tolerance.

Building a Personalized Herbal Protocol

A personalized Ayurvedic protocol usually combines constitutional assessment with the immediate symptom pattern. A depleted Vata pattern may call for Ashwagandha, oil massage, warm meals, and earlier sleep. A Vata-Pitta pattern may need Brahmi, Shankhpushpi, cooling foods, reduced overstimulation, and Bhramari. Anxiety with insomnia may require evening-focused support such as Tagara or Jatamansi, but only after evaluating sedation risk, medication use, and the person’s overall strength.

Timing also matters. Rejuvenative herbs are often given consistently over weeks with food or a suitable Anupana. Sleep-supporting herbs are generally placed in the evening. Medhya herbs may be placed in the morning or early day when the goal is clarity and emotional steadiness. Acute panic, severe insomnia, suicidal thoughts, substance use, bipolar symptoms, psychosis, or inability to function should be treated as medical priorities rather than self-care problems.

Digital Detox and Screen Time Management

Modern anxiety is often intensified by irregular sleep, constant notifications, late-night work, emotionally charged media, and continuous sensory stimulation. From an Ayurvedic viewpoint, fast visual input and fragmented attention increase Vata-like movement in the mind, while late-night screen use can disturb sleep rhythm. A practical digital routine is to stop intense work and social media at least one hour before bed, dim lights, avoid emotionally activating content at night, and replace scrolling with breathwork, reading, prayer, journaling, or a warm bath.

Grounding Daily Routine (Dinacharya)

Dinacharya is valuable for anxiety because regularity directly opposes the unstable, mobile, and erratic qualities of aggravated Vata. The aim is not rigid perfection but a dependable rhythm that the nervous system can recognize as safe. The full Dinacharya protocol is detailed in the Ayurvedic morning routine guide.

1. Wake at a consistent time, preferably early and without immediately checking the phone.
2. Drink warm water and complete elimination without rushing.
3. Apply warm oil for Abhyanga when suitable, especially during dry or stressful periods.
4. Practice 5-15 minutes of Nadi Shodhana or Bhramari.
5. Meditate, pray, journal, or sit quietly before beginning work.
6. Eat a warm breakfast if appetite is present, and keep lunch as the most substantial meal.
7. Take short pauses between tasks to reduce accumulated Vata.
8. Finish heavy work, intense exercise, and stimulating media earlier in the evening.
9. Use a quiet bedtime routine and aim for sleep before late-night Pitta activation.

When Anxiety Requires Professional Mental Health Support

Ayurvedic approaches can support mild stress, constitutional imbalance, sleep regularity, and daily resilience, but anxiety disorders require appropriate mental health care when symptoms are intense, persistent, impairing, or unsafe. Seek urgent professional support if anxiety includes suicidal thoughts, self-harm urges, panic symptoms that resemble a medical emergency, inability to work or maintain relationships, substance use as a coping method, severe insomnia, hallucinations, mania, or symptoms that keep worsening despite self-care.

Ayurvedic herbs can interact with prescription medicines, sedatives, alcohol, thyroid medicines, immune-modulating medicines, and psychiatric drugs. Ashwagandha may cause drowsiness or gastrointestinal symptoms in some people and should be avoided during pregnancy and breastfeeding unless specifically supervised. Valerian-type herbs and Tagara may add to sedative effects. Bacopa may cause gastrointestinal side effects in some people. Always consult a qualified Ayurvedic practitioner and a licensed healthcare provider before starting herbs, changing medication, combining herbs with psychiatric medicines, or treating diagnosed anxiety disorders.

This article provides general Ayurvedic education, not medical advice. Consult a qualified practitioner or healthcare provider before starting any new health protocol, especially if you have a medical condition, are pregnant or breastfeeding, take prescription medicine, or have significant mental health symptoms.

References

1. World Health Organization
2. NCCIH
3. Hopkinsmedicine (hopkinsmedicine.org)
4. Tele-counselling for management of Chittodvega (anxiety disorder) in Ayurveda–composing ancillary methods during the Covid 19 pandemic (2020), PubMed Central
5. Charaka Samhita — Unmada Nidana
6. Charaka Samhita — Psychiatric diseases
7. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study (2019), PubMed
8. Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials (2022), PubMed
9. NIH Office of Dietary Supplements
10. Anxiolytic actions of Nardostachys jatamansi via GABA benzodiazepine channel complex mechanism and its biodistribution studies (2018), PubMed
11. Effects of Nardostachys jatamansi on biogenic amines and inhibitory amino acids in the rat brain (1994), PubMed
12. Powo (powo.science.kew.org)
13. An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood (2014), PubMed
14. Bacopa monniera leaf extract up-regulates tryptophan hydroxylase (TPH2) and serotonin transporter (SERT) expression: implications in memory formation (2011), PubMed
15. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials (2012), PubMed
16. Bacopa monnieri (2026), PubMed
17. Nootropic, anxiolytic and CNS-depressant studies on different plant sources of shankhpushpi (2011), PubMed
18. Role of Shankhpushpi (Convolvulus pluricaulis) in neurological disorders: An umbrella review covering evidence from ethnopharmacology to clinical studies (2022), PubMed
19. Frontiersin (frontiersin.org)
20. A comparative clinical study on the effect of Tagara (Valeriana wallichii DC.) and Jatamansi (Nardostachys jatamansi DC.) in the management of Anidra (primary insomnia) (2015), PubMed
21. 6-methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS (2003), PubMed
22. Role of Shirodhara and Abhyanga on serum cortisol in Anxiety – A case report (2025), PubMed
23. Shirodhara: A psycho-physiological profile in healthy volunteers (2013), PubMed Central
24. Immediate Effects of Bhramari Pranayama on Resting Cardiovascular Parameters in Healthy Adolescents (2016), PubMed Central
25. Effects of Bhramari Pranayama on health – A systematic review (2018), PubMed Central
26. Nature (nature.com)
27. Effect of Alternate Nostril Breathing Exercise on Experimentally Induced Anxiety in Healthy Volunteers Using the Simulated Public Speaking Model: A Randomized Controlled Pilot Study (2017), PubMed Central
28. Easyayurveda (easyayurveda.com)
29. Mapi (mapi.com)
30. Ijapr (ijapr.in)
31. Health benefits of ghee: Review of Ayurveda and modern science perspectives (2024), PubMed Central
32. Health (health.harvard.edu)
33. NCCIH
34. NCBI
35. NCCIH
36. Mskcc (mskcc.org)